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1. SUMMARY 
Replacement of insulin producing β-cells that reside within pancreatic islets 
represents an almost ideal treatment for patients with diabetes mellitus type 
1. But, transplantation of pancreatic islets or the entire pancreas is limited by 
the lack of donor organs. Stem cell derived insulin producing β-cells represent 
an attractive alternative. The major goal of our research project is the ex vivo 
generation of insulin producing cells using adult human stem cells that 
express nestin. Nestin is an intermediate filament protein that was originally 
described as a marker for embryonic and adult stem / progenitor cells of the 
central nervous system. Recently it has been also proposed to be a potential 
stem cell marker in rodent and human islets of Langerhans. Role and function 
of nestin positive pancreatic cells during development or adult life however 
are not well defined and matter of controversial debates. The first aim of our 
research project was to isolate a pure population of nestin expressing cells 
from human pancreatic islets of Langerhans for further characterization. For 
this purpose single cell derived colonies were isolated from cultured human 
islets. These colonies were immortalized and in a second step selected for cells 
with highest nestin promoter activity using promoter targeted selection of 
nestin expressing cells. The second aim was to characterize these cell lines 
especially their stem cell properties and differentiation potential. We 
characterized them finally as potential mesenchymal stem cells (MSC) of 
pancreatic origin based on their expression of different stem cell markers 
including nestin together with the transcription factor Islet-1 (Isl-1) and their 
ability to differentiate in vitro into mesoderm lineages (adipocytes and 
osteoblast-like cells). We could also demonstrate that they are multipotential 
and capable of differentiation into albumin producing liver-like cells in vivo 
and cells with a pancreatic endocrine phenotype in vitro. Based on these 
observations, we wanted to test the hypothesis that human nestin expressing 
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MSC from bone marrow and adipose tissue could equally harbour the 
potential to differentiate into insulin producing cells ex vivo. We found that 
bone marrow and adipose tissue derived MSC are also able to differentiate 
into cells expressing various pancreatic endocrine genes in vitro including 
several crucial transcription factors as well as the islet hormones insulin and 
glucagon. As a limitation of the presented work, we were not yet able to 
generate functional cells that secrete insulin in response to glucose. But, we 
can show for the first time that nestin positive MSC isolated from human 
adult pancreas, bone marrow and adipose tissue represent stem / progenitor 
cells with the potential to induce pancreatic developmental genes. These cells 
may have the capacity to become insulin secreting cells if further manipulated 
and exposed to appropriate microenvironment.  
 
 
 
 
 
 
 
 
 
 
 
 
 - 6 - 
2. INTRODUCTION 
2.1. Diabetes mellitus 
Diabetes mellitus is a debilitating metabolic disease caused by absent 
(juvenile or type 1) or insufficient (type 2) insulin production from β-cells. 
With an actual prevalence of 5.9 % diabetes is affecting 15.7 millions people in 
the USA and approximately 400’000 in Switzerland (data for CH calculated). 
Diabetes is associated with serious long-term complications, such as 
cardiovascular disorders, kidney disease and blindness. The actual treatment 
strategies for type 1 diabetes (5-10 % of all diabetics) are based on insulin 
replacement by several injections daily combined with meticulous blood 
glucose monitoring and life style adaptations. But even under best 
circumstances type 1 diabetic patients are faced with a therapeutic dilemma: 
A good metabolic control that is prerequisite in order to avoid long-term 
complications like retinopathy or nephropathy is associated with a high 
frequency of severe hypoglycaemia [1]. Pancreas and islet transplantation are 
not real treatment alternatives. First of all because of the lack of donor organs, 
but also because of important perioperative complications associated with 
pancreas transplantation and the long-term risk of chronic 
immunosuppression [2,3]. Insulin secreting cells generated from embryonic or 
adult stem cells could represent an attractive alternative [4].  
 
2.2. Stem cells as a potential source for β-cell replacement 
Both embryonic stem cells (ESC) and adult stem / progenitor cells have been 
shown to harbour the ability to induce insulin expression ex vivo when 
exposed to the appropriate stimuli [4]. ESC have the potential for almost 
unlimited supply of insulin producing cells [5] but there are considerable 
ethical concerns associated with the use of human ESC. The generation of 
individual, patient specific stem cell-derived β-cells for transplantation 
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purposes requires therapeutic cloning of human ESC. This is not yet possible. 
Cloning of embryonic stem cells is already accomplished in mice and other 
mammals [6]. The only paper so far that claimed to have cloned human ESC 
reported fabricated data [7]. Another problem is related to the enormous 
proliferative capacity of ESC and the risk for development of teratocarcinoma. 
Therefore, many scientists continue to work with adult stem / progenitor cells. 
Large body of evidence indicates that such adult stem / progenitor cells are 
present in the pancreas. They were described in pancreatic islets [8,9,10], 
pancreatic ducts [11], among the population of pancreatic acinar cells [12-14] 
and in adult or fetal pancreas without further specification [15-17]. Adult stem 
/ progenitor cells with the potential to differentiate into insulin producing 
cells have been also found outside the pancreas namely in the liver [18,19], 
central nervous system [20], spleen [21], skin [22] and bone marrow [23-26] 
indicating a greater developmental plasticity of adult stem / progenitor cells 
than was previously appreciated. Although the mechanisms are poorly 
understood and the differentiation efficacy is quite limited, it seems that adult 
stem / progenitor cells within and outside the pancreas can be converted into 
insulin producing cells. In this context, they should follow at least in part the 
complex program of normal pancreas development.    
 
2.3. Transcriptional regulation of pancreas development 
The adult pancreas is a mixed organ that contains three different cell types: 
the ductal tree, the exocrine acini that produce digestive enzyme, and the 
endocrine islets of Langerhans. They are embedded within the exocrine tissue 
and consist of four distinct cell types: α-, β-, δ- and PP-cells, which produce 
the key hormones glucagon, insulin, somatostatin and pancreatic polypeptide, 
respectively (Figure 1). During embryogenesis, the pancreas develops as an 
outgrowth at the foregut endoderm from epithelial cells that branch into the 
surrounding mesenchyme and fuse to form finally the mature organ. 
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Interactions between these epithelial and mesenchymal cells direct then 
pancreatic development towards endocrine or exocrine fate [27]. The first step 
of pancreas formation needs the suppression of sonic hedgehog (SHH) 
signalling by factors like activin and fibroblast growth factors in pre-
patterned, restricted areas of the endoderm [28,29] thereby allowing the 
induction of the transcription factor Ipf-1 that is prerequisite for pancreas 
development. Loss of function mutation of Ipf-1 results in pancreas agenesis 
in mouse and man [30,31]. After this initial period, the coordinated and 
tightly controlled activation of various crucial transcription factors including 
Isl-1, Ngn3, Pax4, Pax6, Nkx2.2 and Nkx6.1 orchestrates the development of 
the pancreas and pancreatic endocrine cells. Isl-1 is together with Ipf-1 one of 
the earliest pancreatic markers detected in the pancreatic anlage at embryonic 
day e9 in the mouse [32]. During pancreas development Isl-1 is expressed in 
mesenchymal and epithelial cells and has been demonstrated to be crucial for 
the differentiation of endocrine cells. Explants of fetal pancreas from Isl-1 
knockout mice are not able to generate endocrine cells as compared to 
wildtype animals [32]. At day e9-9.5 Ngn-3 is induced, another important step 
toward pancreatic endocrine cells. Ngn3 has recently been shown to be 
involved in the development of all four endocrine cell types [33], and Ngn3 
positive cells have been widely regarded as the real progenitors of hormone 
producing islet cells [34]. In the adult pancreas no Ngn-3 expression is 
detected. Pax4 and Pax6 are expressed both in the developing gut and in the 
adult pancreas. Pax6 is required for the generation of glucagon secreting α-
cells [35], whereas Pax4 plays a role in the differentiation of insulin producing 
β-cells and somatostatin producing δ-cells [36]. Nkx2.2 was shown to be 
involved in the early development of pancreatic β-cells [37] and Nkx6.1 is 
expressed primarily in β-cells of the adult islets [38]. Finally in adult pancreas, 
Ipf-1 is induced and regulates the expression of insulin in differentiated β-
cells.  
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Figure 1.  
Histology of the human pancreas. A. An islet of Langerhans is surrounded by 
exocrine tissue (Immunostaining for C-peptide). B. Human islet cluster (phase 
contrast).  
Most of these transcription factors are sequentially and transiently expressed 
during development (Figure 2.). Although pancreas development has been 
partly deciphered by identification and characterization of many transcription 
factors little is known about their function and molecular mechanism of 
action.  
Differentiation of stem / progenitor cells into insulin producing cells in vitro 
should follow at least the major part of this transcriptional program. Adult 
stem cells cultured in vitro however may face certain limitations due to the 
lack of an appropriate in vivo environment and some crucial in vivo factors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 - 10 - 
Figure 2.  
Schematic representation of putative differentiation pathways leading from stem / 
progenitor cells to pancreatic β-cells. The proposed model of the hierarchy of 
transcription factors is based on the temporal expression and phenotypic results of 
gene specific knockouts (after Schwitzgebel et al. 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
. 
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3. MAIN FINDINGS AND GENERAL DISCUSSION 
Cells in human pancreatic islets of Langerhans proliferate and start to express 
nestin when cultured in medium supplemented with serum and growth 
factors including FGF2 and EGF [8]. In order to show that nestin expressing 
cells have stem cell potential in vitro single cell cultures were isolated from 
cultured human islets. Single cell derived colonies were positive not only for 
nestin but also for Isl-1 whereas Ipf-1 as well as Insulin expression were 
negative. In order to ensure robust and sustained proliferation, cells were 
reversibly immortalized using CRE-Lox excisable lentiviral vectors over-
expressing the hTelomerase and / or mBmi-1, a combination of genes which 
was described to be optimal for reversible immortalization of primary human 
cells [39] (Lentiviral transductions were performed by Patrick Salmon, 
University Hospital Geneva). These modified cell lines continued to express 
nestin and Isl-1. Whereas nestin is accepted as a marker of neural stem / 
progenitor cells, the pattern of expression and role of nestin during pancreas 
development remain controversial [40-47]. The transcription factor Isl-1 is 
known to play a crucial role in the development of endocrine pancreatic cells 
[32]. During embryogenesis, nestin and Isl-1 positive cells are found in the 
pancreatic mesenchyme surrounding the epithelial cells that equally express 
Isl-1 themselves [32,46]. In view of this co-expression of nestin and Isl-1 in 
pancreatic mesenchyme during development, we assumed to have isolated 
MSC from cultured pancreatic islets. This hypothesis was further supported 
by their ability to differentiate in vitro into mesoderm lineages like adipocytes 
(Figure 3) and osteoblast-like cells (Figure 4). In addition, these immortalized 
cells have the potential to acquire a hepatic phenotype in vivo when 
transplanted into the liver of immune deficient SCID mouse demonstrating 
for the first time in vivo that multipotential stem / progenitor cells may exist in 
human pancreatic islets (Figure 5). This part of the project was performed in 
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collaboration with Marc von Mach (University Hospital Mainz, Germany) and 
Jan Georg Hengstler (University of Leipzig, Germany). Similar results were 
obtained with a population of cultured nestin expressing human islet cells. 
They were also able to engraft into SCID mouse liver and produced human 
albumin 3 weeks after transplantation (Figure 6). The mechanisms underlying 
this phenomenon seem to be transdifferentiation although fusion with host 
hepatocytes cannot be completely ruled out. These results support the idea of 
common hepato-pancreatic stem / progenitor cells that may reside within the 
pancreas as well as the liver. During embryogenesis, both organs are believed 
to origin from similar endodermal progenitor cells [48] and there is evidence 
indicating that such progenitors with the potential to generate liver cells from 
pancreatic cells and vice versa are still present in adult life [49-51,18,19].  
Surprisingly, MSC isolated from human bone marrow were also able to 
differentiate into hepatocytes without evidence for cell fusion if xenografted 
directly into the rat liver [52] demonstrating that MSC are able to cross the 
mesodermal lineage and give rise to endoderm in vivo.  
Using a new differentiation protocol for the generation of insulin producing 
cells from our immortalized pancreatic MSC resulted in expression or up-
regulation of various key transcription factors like Ipf-1, Isl-1, Pax-4, Pax-6, 
Nkx2.2, Nkx6.1 and Ngn-3 as well as the islet genes insulin, glucagon and 
somatostatin (Figure 7). Our differentiation conditions included serum free 
medium enriched with B-27 supplement, N-2 supplement, exendin-4, 
nicotinamide, hepatocyte growth factor, activin-A and pentagastrin, all factors 
known to have beneficial effects on differentiation of stem / progenitor cells 
into insulin producing cells [10,53-55]. Although C-peptide containing 
granules were found as an indicator for de-novo insulin synthesis in some 
differentiated cells (Figure 7), they were not yet able to secret C-peptide in 
response to glucose indicating a certain level of developmental immaturity. 
De-immortalization of the islet derived MSC could render them more 
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Figure 3.  
Differentiation into adipocytes in vitro. A. After culturing for 2-3 weeks in adipogenic 
differentiation medium, immortalized cells formed fat droplets as visualized by oil red 
staining. Nuclear staining was performed with DAPI. Original magnification x400. B. 
Expression of adipocyte-specific genes PPARγ2, adiponectin, and leptin in 
differentiated cells (N). The adipocyte-specific genes are not expressed by cultured 
immortalized cells (not shown). Mesenchymal stem cell derived adipocytes were used 
as positive control (M).  
 
susceptible to adopt an endocrine phenotype and may lead to insulin 
producing and secreting cells. (Eberhardt M*, Salmon P*, von Mach MA, 
Hengstler JG, Brulport M, Linscheid P, Seboek D, Oberholzer J, Barbero A, 
Martin I, Müller B, Trono D and Zulewski H. "Multipotential nestin and Isl-1 
positive mesenchymal stem cells isolated from human pancreatic islets". Biochem 
Biophys Res Commun 2006; 345: 1167 – 1178) and (von Mach MA, Hengstler 
JG, Marc Brulport M, Eberhardt M,  Schormann W, Hermes M, Prawitt D, 
Zabel B, Grosche J, Reichenbach A, Müller B, Weilemann LS and Zulewski H. 
"In vitro cultured islet-derived progenitor cells of human origin express human 
albumin in SCID mouse liver in vivo". Stem Cells 2004; 22: 1134 – 1141) 
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Figure 4.  
Differentiation into an osteoblast-like phenotype in vitro. A. Alkaline phosphatase 
(AP) activity increases during culture of immortalized cells (BC11-BT) in osteogenic 
medium (OM) reaching levels comparable to those expressed by bone marrow derived 
mesenchymal stem cells (BMSC). B. AP positive cells were stained in blue. Original 
magnification x400. C. BC11-BT cells formed foci of mineralization visualized by 
Alizarin red after 3 weeks’ culture in OM.  BMSC cultured in OM were used as 
positive control, BC11-BT cells cultured without OM were used as negative control. 
Original magnification x100. 
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Figure 5.  
Differentiation into a hepatic phenotype in vivo. Immunohistochemistry 3 weeks after 
transplantation of human immortalized pancreatic cells into SCID mouse liver using a 
monoclonal antibody specific for human albumin and diaminobenzidine (brown) for 
staining (A), nontransplanted SCID mouse liver as negative control (B), and human 
liver (C) as positive control (bar = 20 µm).  
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Figure 6.  
Differentiation into a hepatic phenotype in vivo. Fluorescence-immunohistochemistry 
with human and mouse specific antibodies against albumin using confocal microscopy 
(magnification x630). (A): One cell stained with antibodies against human albumin. 
(B): The same cell with additional 4',6'-diamidino-2-phenylindole staining for cell 
nuclei. (C): Albumin staining with antibodies against mouse albumin. (D): Digital 
overlay of human and mouse albumin staining showing no co-staining for mouse 
albumin in the human albumin-positive cell. 
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Figure 7. 
Differentiation into an endocrine phenotype in vitro. A. After 4 days of culture in 
differentiation medium the cells formed islet like clusters (phase contrast image). B. 
Expression of transcription factors known to play an important role in pancreatic 
endocrine formation including Ipf-1, Isl-1, Ngn3, Pax4, Pax6, Nkx2.2, and Nkx6.1 as 
well as the mRNA transcripts of the islet hormones insulin, glucagon and somatostatin. 
C. Electron microscopy studies revealed formation of granules in differentiated cells in 
contrast to undifferentiated cells (not shown). Red arrows indicate immunogold 
labeling for C-peptide (inset). 
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The developmental origin of our islet derived nestin and Isl-1 positive MSC 
however remains somewhat elusive. They could represent indigenous stem / 
progenitor cells present in the adult pancreas or originate from non pancreatic 
tissue like bone marrow and belong to a pool of circulating stem / progenitor 
cells [56] that also reside in the pancreas. As well, pancreatic epithelial β-cells 
could de-differentiate into nestin positive cells of a mesenchymal phenotype 
by the mechanism of epithelial to mesenchymal transition (EMT). Epithelial 
cells are known to undergo EMT when placed in culture in the presence of 
high serum concentrations and supplemented with growth factors such as 
FGF2 and EGF [57-61]. Stem / progenitor cells with a mesenchymal phenotype 
have been described to arise in human islet cultures by EMT induced by 
growth factors [62]. Upon culture in serum containing medium decrease of C-
peptide positive cells was observed together with concomitant increase of 
nestin positive cells. Besides nestin, they expressed vimentin and were able to 
re-differentiate into insulin expressing cells given the appropriate stimuli.  
Whether EMT occurs in vivo in adult pancreas is unknown, but it could 
explain the controversial report questioned the entire concept of stem / 
progenitor cells in adult pancreas [63].  In this study, it has been shown that 
pre-existing β-cells rather than stem / progenitor cells are the major source of 
new β-cells concluding that adult β-cells are formed by self-duplication. The 
possibility of stem / progenitor cells to play a role in β-cells replacement in 
adult life was almost excluded. However, another interpretation of these data 
is that new β-cells can be generated from pre-existing β-cells by EMT 
indicating that this mechanism may occur in vivo in pancreas.  
Expanding the concept of EMT, MSC from other organs like bone marrow or 
adipose tissue could also harbour the potential to differentiate into an 
endocrine pancreatic phenotype. Bone marrow derived MSC can differentiate 
into hepatocytes in vitro and in vivo [52,64] and hepatic progenitor cells are 
able to generate insulin producing cells in vitro [18,19]. MSC isolated from 
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murine and rat bone marrow were already shown to have the capacity to 
differentiate into insulin secreting cells in vitro and to reverse hyperglycaemia 
in an animal model of diabetes [26,65]. Furthermore, human bone marrow 
derived MSC were described to express at low level the islet transcription 
factor Nkx-6.1 and they were able to differentiate into insulin expressing cells 
upon adenoviral transduction with vectors encoding the transcription factors 
Ipf-1, Hlxb-6 or Foxa-2 [66]. Thus, the developmental potential of cultured 
MSC could include the differentiation in cells of endodermal origin like the 
liver and perhaps even the endocrine pancreas. Interestingly, MSC were also 
shown to bear the potential to adopt a neural phenotype in vitro and in vivo in 
rodents and humans [67-70] suggesting a neuro-endocrine developmental 
capacity of these cells.  
We have isolated MSC from human bone marrow as well as from adipose 
tissue and observed a similar induction of pancreatic developmental 
transcription factors including the islet genes insulin, glucagon and 
somatostatin (Figures 8 and 9). Noteworthy, this was achieved without any 
genetic modification. Importantly, bone marrow derived MSC from patients 
with long standing type 1 diabetes were also induced to express insulin and 
glucagon in a similar way (Seboek D*, Timper K*, Eberhardt M, Linscheid P, 
Keller U, Martin I, Barbero A, Müller B and Zulewski H. "Human mesenchymal 
stem cells from non-diabetic and type 1 diabetic patients differentiate into insulin, 
somatostatin and glucagon expressing cells". In preparation) and (Timper K*, 
Seboek D*, Eberhardt M, Linscheid P, Christ-Crain M, Keller U, Müller B and 
Zulewski H. "Human adipose tissue-derived mesenchymal stem cells differentiate 
into insulin, somatostatin and glucagon expressing cells". Biochem Biophys Res 
Commun 2006; 341: 1135 – 1140) 
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Figure 8.  
Analysis of islet like clusters from bone marrow derived MSC from non-diabetic 
patients. A. Phase contrast image of islet like clusters after differentiation 
(magnification x200). B. Staining of a differentiated islet like cluster for C-peptide 
after 3 days in differentiation medium. Nuclear staining was performed in blue with 
DAPI (magnification x200). C. Induction of insulin, somatostatin and glucagon in 
response to defined culture conditions. Gene expression was monitored every 24h for 3 
days. Data are normalized to HPRT and expressed as percentage expression as 
compared to day 0. Results are means ± SEM of quadruplicates of 6 independent 
experiments from 5 independent donors.  
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Figure 9.  
Analysis of islet like clusters from adipose tissue derived MSC. A. 
Immunocytochemistry for C-peptide in differentiated adipose tissue derived MSC after 
3 days in differentiation medium. Single cells were stained for c-peptide (magnification 
x200). Nuclear staining was performed in blue with DAPI. B. Induction of insulin, 
somatostatin and glucagon in response to defined culture conditions. Gene expression 
was monitored every 24h for 3 days. Data are normalized to HPRT and expressed as 
percentage expression as compared to day 0. Results are means ± SEM of 
quadruplicates of 4 independent experiments from 4 independent donors.  
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Although a release of somatostatin was detected, we were not yet able to 
measure C-peptide. But, for the first time we could show that cultured human 
MSC from the bone marrow as well as adipose tissue may have the potential 
to adopt a pancreatic endocrine phenotype without any genetic modification.  
The beneficial effect of our differentiation medium was also tested in another 
human cell system in a collaborative project with Claes Wollheim and Benoit 
Gauthier (University of Geneva). Macrophage-colony stimulating factor (M-
CSF) treated peripheral blood monocytes [71,72] were shown to differentiate 
into various cell types including insulin expressing cells. Interestingly, 
adenoviral-mediated forced expression of key pancreatic transcription factors 
like mPdx1, mNgn3 and mPax4 in M-CSF treated human monocytes did not 
generate insulin expressing cells. Treatment with our defined differentiation 
medium however resulted in a sustained up-regulation of key transcription 
factors as well as insulin and glucagon (data not shown).  
Our cultured MSC isolated from pancreas, bone marrow and adipose tissue 
express all nestin but also Isl-1. The appearance of nestin and Isl-1 positive 
cells is most likely the result of our in vitro conditions. Numerous cell types 
start to express nestin after in vitro cultivation and they are believed to be 
stem / progenitor cells [8,10,16,67,68,73]. Nestin expression has been therefore 
proposed to be a property of in vitro multilineage stem / progenitor cells [74]. 
An explanation for isolation of Isl-1 positive cells from pancreatic islets could 
be the mechanism of EMT. Following this hypothesis endocrine cells which 
are positive for Isl-1 may have maintained their Isl-1 expression during the 
de-differentiation into MSC. If the concept of EMT holds true one could argue 
that Isl-1 positive MSC from other sources could also harbour the potential to 
differentiate into an endocrine pancreatic phenotype if exposed to appropriate 
culture conditions. Isl-1 expression in our bone marrow and adipose tissue 
derived MSC may thus represent a critical event that allowed the 
differentiation into an endocrine pancreatic phenotype with expression of 
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insulin, glucagon and somatostatin in vitro. But, Isl-1 is also involved in the 
development of the central nervous system especially motorneurons [75,76] 
and it has been recently also shown to be involved in the development of the 
heart [77,78]. Thus, at least some of our Isl-1 positive MSC may also represent 
potential precursors for these organs as well.  Beside nestin and Isl-1 our 
proliferating MSC are also positive for ABCG2 which was described as a stem 
cell marker for the side population phenotype in bone marrow [79]. Recently 
ABCG2 was also found in neural stem cell and pancreatic islet derived 
progenitor cells [80,81]. Nestin and possibly ABCG2 expression could 
therefore represent a possible link between MSC and their ability to 
differentiate into neuro-endocrine cells. 
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4. OUTLOOK / FUTURE PERSPECTIVES 
There is an increasing body of evidence suggesting that MSC are able to 
differentiate into insulin producing cells and to correct hyperglycaemia, at 
least in rodents [21,24,26]. Although our isolated MSC from human pancreas, 
bone marrow and adipose tissue have the potential to undergo differentiation 
into an endocrine phenotype these cells were not yet able to secrete C-peptide 
in response to glucose. Some of the factors needed to generate insulin 
expressing cells in MSC are included in our differentiation cocktail, but 
important elements are still lacking.  
Organisation and differentiation of stem / progenitor cells during 
development occur in a well defined spatial and temporal context. Signals 
involved in cell fate decisions like SHH exert their effect also as gradient 
morphogens [82]. This concept of development may also apply to adult stem / 
progenitor cells. During development SHH signalling inhibits pancreas 
formation and differentiation of endocrine cells in embryonic tissue explants 
whereas suppression of SHH signalling with cyclopamine promotes pancreas 
formation [83]. Interestingly, SHH signalling pathway is known to be 
involved in cell proliferation and cyclopamine was shown to suppress the 
expression of nestin as well as Bmi-1 that is needed for self renewal of adult 
stem cells [84,85]. Our preliminary data show that genes required for 
transduction of hedgehog signals like Gli1, Patched and smoothened are 
expressed in proliferating bone marrow derived MSC (Figure 10A). 
Interestingly, when they were analysed before and after induction of 
differentiation we observed a down-regulation of the hedgehog target gene 
Gli1 that represents a direct readout of the hedgehog signalling pathway 
(Figure 10B). In addition, treatment with 10µM cyclopamine for 72 hours was 
associated with an increase in Isl-1 expression (Figure 10C). This first pilot 
experiment indicates that SHH signalling may play an important role in 
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Figure 10. 
Sonic hedgehog signaling pathway is involved in human bone marrow derived mesenchymal 
stem cells (bMSC) A. RT-PCR analysis showed that mRNA of Sonic (Shh) and Indian (Ihh) 
hedgehog as well as target genes of the Shh signaling pathway including Gli1, Patched (Ptc) 
and Smoothened (Smo) are expressed in bMSC whereas Desert (Dhh) hedgehog is not found. 
B. Down-regulation of Gli1 mRNA of human bMSC after differentiation for 3 days into cells 
with pancreatic endocrine phenotype. C. Human bMSC were treated with cyclopamine (0µM, 
1µM and 10µM) for 72 h and analyzed by RT-PCR. SHH target gene Gli1 is down-regulated 
whereas the crucial pancreatic endocrine transcription factor Isl-1 is up-regulated. Adenine 
phosphoribosyltransferase (APRT) was used as positive control for RT-PCR. 
 
proliferation and differentiation of bone marrow derived MSC. A pre-
incubation with cyclopamine could therefore help to improve their 
differentiation efficacy. A prolonged culture for additional days after 
induction of differentiation may also enhance the maturation of islet like 
clusters.  
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In addition, MSC derived insulin expressing islet like clusters have to be 
further characterized regarding their functional properties. This includes 
analysis of glucose dependent C-peptide release as well as their potential to 
correct hyperglycaemia in an animal model of diabetes. Islet like clusters have 
been shown to undergo a significant maturation after transplantation in vivo 
and to reverse diabetes in an animal model [15,16,24]. 
Using our differentiation protocol the formation of islet like clusters is 
difficult to control. The floating clusters in the ultra-low attachment tissue 
culture dishes differ considerably in size. Too many cells in one cluster may 
lead to apoptosis in the centre of the cluster because of reduced access for 
oxygen and nutrients. But it is likely that also local factors secreted within 
these clusters are crucial for differentiation. Thus, a critical cell size may be 
required and has to be defined for optimal differentiation of MSC into insulin 
producing cells. The optimal numbers of MSC for best insulin expression 
could be evaluated using the hanging drop technique that allows the 
deposition of a defined cell number in a defined volume of differentiation 
medium. 
 
In conclusion, the work presented herein demonstrate for the first time that 
human MSC from various tissues are able to induce pancreatic endocrine 
genes including crucial transcription factors as well as glucagon, somatostatin 
and insulin. Further studies are required to enhance the differentiation 
efficacy. 
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Mesenchymal cells in the developing pancreas express the neural stem cell marker nestin and the transcription factor islet-1 (Isl-1).
Using defined culture conditions we isolated on a single cell basis nestin producing cells from human pancreatic islets. These cells were
immortalized with lentiviral vectors coding for telomerase and mBmi. They are positive for Isl-1 and nestin and have the potential to
adopt a pancreatic endocrine phenotype with expression of critical transcription factors including Ipf-1, Isl-1, Ngn-3, Pax4, Pax6,
Nkx2.2, and Nkx6.1 as well as the islet hormones insulin, glucagon, and somatostatin. In addition, they can be differentiated into human
albumin producing cells in vivo when grafted into a SCID mouse liver. In accordance with a mesenchymal phenotype, the cells were also
able to adopt adipocytic or osteocytic phenotypes in vitro. In conclusion, cultured pancreatic islets contain nestin and Isl-1 positive mes-
enchymal stem cells with multipotential developmental capacity.
 2006 Elsevier Inc. All rights reserved.
Keywords: Human; Pancreatic islet; Nestin; Mesenchymal stem cells; ABCG2; Isl-1; Differentiation; Diabetes; Insulin; AlbuminThe development of normal pancreas is the result of
close interaction between mesenchymal and epithelial cells
that form the initial buds. Signals from mesenchymal
cells direct pancreatic development towards endocrine or0006-291X/$ - see front matter  2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.bbrc.2006.05.016
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5100 (H. Zulewski).
E-mail addresses: Didier.trono@epfl.ch (D. Trono), henryk.zulewski@
unibas.ch (H. Zulewski).
1 These authors contributed equally to this work.exocrine fate [1]. Mesenchymal cells of the developing pan-
creas express islet 1 (Isl-1) [2], an essential transcriptional
factor for the generation of endocrine cells and nestin [3],
a neural stem cell marker [4] that was also identified within
adult pancreatic islets [5]. Fate and function of pancreatic
mesenchymal cells in postnatal life are unknown. They
could represent a population of dormant mesenchymal
stem cells (MSC) with the potential to differentiate into
pancreatic endocrine or even hepatic phenotype given
the appropriate stimuli [5]. Accordingly in recent in vitro
1168 M. Eberhardt et al. / Biochemical and Biophysical Research Communications 345 (2006) 1167–1176studies nestin positive cells isolated from fetal human pan-
creas could be differentiated into insulin producing cells
and cured diabetes in an animal model [6,7].
Here we demonstrate that multipotent mesenchymal
cells can be found in primary cultures of human islets.
We further describe the isolation and immortalization of
single cell derived nestin and Isl-1 positive cells from adult
human islets of Langerhans. These cells display a mesen-
chymal phenotype and can be induced to differentiate
towards a pancreatic endocrine, an adipocytic or an osteo-
cytic phenotype in vitro and a hepatic phenotype in vivo.Research design and methods
Cell culture studies. Human islet tissue was obtained from the Islet
Transplantation Center in Geneva University Hospital, (Geneva Swit-
zerland). Nestin positive islet derived progenitor cells were isolated as
described previously [5]. Briefly, islets were washed and cultured in
expansion medium (RPMI 1640 medium containing 10% fetal bovine
serum, antibiotics, sodium pyruvate (1 mM), Hepes (10 mM), and
b-mercaptoethanol (50 mM)). Within several days, nestin positive cells
grew out from islets. These cells were expanded in medium containing
20 ng/ml each of FGF2 and EGF. After two passages, cells were re-sus-
pended in a single cell suspension and subjected to a single cell deposition
treatment by a FACS (Becton–Dickinson, Palo Alto, CA). EGF was from
Sigma (Buchs, Switzerland). All other reagents were from Invitrogen/
Gibco BRL (Basel, Switzerland).
Cell transduction using lentiviral vectors. HLOX vectors used for
immortalization (pLOX-CW-Bmi1 and pLOX-TERT-iresTK) have been
described previously [8,9], and express the murine Bmi-1 cDNA [10]
(GenBank No. M64067) and the human hTERT cDNA (GenBank No.
AF018167) followed by the thymidine kinase of Herpes simplex virus type
1 (HSV1-TK), respectively, in a pLox backbone. The vector used for
transcription activated cell sorting (TRACS) was constructed as follows.
Briefly, the neuron-specific GFP transgene described by Yamaguchi et al.
[11] and comprising the rat nestin promoter, the EGFP cDNA (Clontech),
the neuron-specific second intron of the rat nestin gene, and the chickenTable 1
Primer sequences for RT-PCR
Gene Sense primer Antisense primer
Nestin 5 0-CGTTGGAACAGAGGTTGGAG-30 5 0-TAAGAAAG
ABCG2 5 0-CACAGGTGGAGGCAAATCTT-30 5 0-TCCAGACA
Thy-1 5 0-GTCCTTTCTCCCCCAATCTC-30 5 0-GGGAGACC
SCF 5 0-GGTGGCAAATCTTCCAAAAG-3 0 5 0-TCTTTCACG
c-Kit 5 0-GGCATCACGGTGACTTCAAT-30 5 0-GGTTTGGG
Isl-1 5 0-GTTACCAGCCACCTTGGAAA-30 5 0-TTCCCACTT
Insulin 5 0-GGCTTCTTCTACACACCCAAG-3 0 5 0-CATCTCTCT
Glucagon 5 0-CCCAAGATTTTGTGCAGTGGTT-3 0 5 0-CAGCATGT
Somatostatin 5 0-GATGCCCTGGAACCTGAAGA-3 0 5 0-CCGGGTTTG
Ipf-1 5 0-CCTTTCCCATGGATGAAGTC-3 0 5 0-TTGTCCTCC
Ngn-3 5 0-CTATTCTTTTGCGCCGGTAGA-30 5 0-CTCACGGG
Pax-4 5 0-TCTCCTCCATCAACCGAGTC-3 0 5 0-GTTGGAAA
Pax-6 5 0-TGCGACATTTCCCGAATTCT-30 5 0-GATGGAGC
Nkx2.2 5 0-TCTACGACAGCAGCGACAAC-30 5 0-TTGTCATTG
Nkx6.1 5 0-TCTTCTGGCCCGGAGTGA-30 5 0-CCAACAAA
Albumin 5 0-ACTTTTATGCCCCGGAACTC-30 5 0-AGCAGCAG
PPARc2 5 0-GCGATTCCTTCACTGATAC-30 5 0-GCATTATGA
Leptin 5 0-TGCCCATCCAAAAAGTCCA-3 0 5 0-GAAGTCCA
Adiponectin 5 0-TGGGCCATCTCCTCCTCA-30 5 0-AATAGCAG
APRT 5 0-GCGTGGTATTCAGGGACATC-3 0 5 0-CAGGGCGT
All primers were run at 60 C.b-globin polyadenylation signal was inserted in opposite orientation into a
CCL-LoxP HIV-1 derived vector. Detailed maps and sequences of the
lentiviral vectors used in this study can be obtained at http://
www.medecine.unige.ch/~salmon.
Production of HIV derived vectors pseudotyped with the VSV G
envelope protein was achieved by transient co-transfection of three plas-
mids into 293T epithelial cell line as previously described [12]. Titers of LV
stocks were determined by transduction of target cells and measuring of
the fraction of transgene-expressing cells by flow cytometry (for GFP-
expressing vectors) or number of integrated proviral genomes by quanti-
tative PCR (for Bmi-1 or hTERT-expressing vectors). Details on titration
techniques are available at http://www.medecine.unige.ch/~salmon. The
functionality of the nestin-GFP LV was assessed by transduction of the
nestin-expressing NFSK-1 human neuronal cell line (ATCC CRL-2060).
The tissue-specificity of the nestin-GFP cassette in the context of the
lentiviral vector was confirmed by GFP expression in NFSK cells and
absence of GFP expression in HeLa cells (data not shown). Using a
ubiquitous promoter (PGK or EF1), NFSK and HeLa cells were shown to
be equally transduceable by LVs (data not shown). Titers of nestin-GFP
LV stocks as determined by FACS on NFSK cells were thus considered
equivalent to titers determined on HeLa cells. BC11 cells were transduced
by lentiviral vectors at multiplicities of infection (MOI) ranging from 0.5
to 2.
Reverse transcription and polymerase chain reaction. Total RNA from
human islets, cell cultures, and liver samples was extracted with TRIzol
reagent (Lucerna Chemie AG, Switzerland). RNA (1 lg) was then reverse
transcribed using Omniscript (Qiagen, Basel, Switzerland) and amplified
by polymerase chain reaction (PCR) using Taq PCR core kit (Qiagen).
Negative controls without reverse transcriptase enzyme were run in par-
allel to exclude possible contamination. Human gene-specific, intron
spanning primers are listed in Table 1. PCR products were separated and
visualized on agarose gels containing 0.5 lg/ml ethidium bromide (EtBr,
Bio-Rad Laboratories AG, Reinach, Switzerland). One hundred bp
molecular ruler (Bio-Rad) was run as size reference. PCR product identity
was confirmed by nucleotide sequencing (Microsynth AG, Balgach,
Switzerland).
Differentiation of immortalized BC11 cells. For differentiation into an
endocrine phenotype, 90% confluent BC11 cells were trypsinized and
seeded in low attachment plates (Vitaris, Baar, Switzerland) containing
serum-free DMEM-F12 medium (17.5 mM) supplemented with B-27Amplicon (bp) Accession No. Cycles
GCTGGCACAGGT-30 396 BC032580 40
CACCACGGATAA-3 0 322 AY289766 40
TGCAAGACTGTT-30 239 NM_033209 40
CACTCCACAAG-30 222 BC074725 40
GAATGCTTCATA-30 244 L04143 40
TCTCCAACAGG-30 240 BC031213 40
CGGTGCAGGA-3 0 248 AY138590 40
CTCTCAAATTCATCGT-30 80 NM_002054 40
AGTTAGCAGATCT-3 0 82 BC032625 40
TCCTTTTTCCA-30 269 AF035259 40
TCACTTGGACAGT-30 73 NM_020999 40
ACCAGACCCTCA-3 0 299 AF043978 40
CAGTCTCGTAATACCT-3 0 81 NM_001604 40
TCCGGTGACTC-30 154 O95096 40
ATGGATCCTTGATGA-3 0 84 NM_006168 40
CACGACAGAGTA-3 0 598 NM_000477 40
GACATCCCCAC-30 580 NM_015869 40
AACCGGTGACTTTCT-30 122 NM_000230 40
TAGAACAGCTCCCAGC-3 0 103 NM_004797 40
CTTTCTGAATCT-3 0 284 NM_000485 28
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exendin-4 (10 nM), hepatocyte growth factor (100 pM), and pentagastrin
(10 nM). After 4 days, cells were collected for further experiments and
analysis. Culture medium, B-27 supplement, and N-2 supplement were
obtained from Invitrogen/Gibco BRL (Basel, Switzerland). All other
reagents were from Sigma (Buchs, Switzerland) except for pentagastrin
that was from Cambridge Laboratories, Newcastle Upon Tyne, UK.
Differentiation into an adipocyte or osteoblastic phenotype was performed
with the same culture conditions normally applied for adipocytic or
osteoblastic differentiation of bone marrow derived mesenchymal stem
cells (BMSC) or preadipocytes [13,14]. For these studies BMSC have been
used as control cells.
In vivo investigations. 300.000 BC11 cells were transplanted into the
livers of four SCID mice as described previously [15]. After 35 days, the
injected liver lobes were excised and shock frozen in liquid nitrogen.
RT-PCR analysis was performed for human albumin as described above.
For immunohistochemistry the specimens were transferred to 4% para-
formaldehyde and embedded into paraffin. Peroxidase was blocked in
7.5% H2O2 in methanol for 60 min at 4 C. Unspecific binding-sites were
blocked in 3% BSA (bovine serum albumin) for 2.5 h at 37 C. Afterwards,
an avidin/biotin-block (Vector Laboratories, Inc., Burlingame, CA) was
performed as described by the manufacturer. Slides were then incubated
with a 1:50 dilution of an affinity purified human albumin antibody pro-
duced in goat (Bethyl Laboratories, Inc., Montgomery, TX; Cat. No. A80-
229A) for 60 min at rt. Detection of the first antibody was performed using
commercial Vectastain Elite ABC Kit (Vector Laboratories) as described
by the manufacturer, followed by a 5 min incubation with 0.6 mg/mL
diaminobenzidine at room temperature. Finally the sections were coun-
terstained with a 1:5 dilution of Mayer’s hemalum (Merck, Darmstadt,
Germany).
Histochemical stainings. Differentiated cells were rinsed off with PBS
and fixed in 4% formaldehyde for 30 min. Standard Oil Red O, alkaline
phosphatase, and Alizarin Red staining were performed as previously
described [16].
Immunocytochemistry. Expanded cells were transferred into Lab-Tek
chamber slides (Nunc, Naperville, IL) and incubated overnight in
expansion medium. Islet-like clusters were collected after 4 days in dif-
ferentiation medium, transferred onto glass slides coated with poly-L-
lysine (Sigma), and incubated overnight in DMEM-F12 medium
containing 10% FCS. All cells were fixed with 4% paraformaldehyde in
PBS (pH 7.4) for 30 min at rt. After several rinses in PBS, cells were
permeabilized with chilled methanol for 10 min. To prevent unspecific
bindings they were then incubated with 10% fetal bovine serum in PBS at
rt for 30 min. Expanded cells were incubated with primary antisera for 3 h
at rt or overnight at 4 C, rinsed off with PBS, and incubated with sec-
ondary antisera for 1 h at rt. Islet-like clusters were incubated with pri-
mary antisera for 60–90 min at 37 C, rinsed off with PBS, and incubated
with secondary goat antisera for 45 min at 37 C. After several washes
with PBS, they were finally coverslipped with non-fluorescing mounting
medium. The primary antibodies used were rabbit anti-nestin (dilution
1:200) (Chemicon, Juro Supply, Lucerne, Switzerland), rabbit anti-human
c-peptide (dilution 1:1000) (Linco, St. Charles, MO), and rabbit anti-
glucagon (dilution 1:100) (Linco, St. Charles, MO). Mouse anti Isl-1
39.4D5 (1:100 dilution) was obtained from the Developmental Studies
Hybridoma Bank, University of Iowa, USA. The secondary antibodies
from Molecular Probes (Invitrogen/Gibco BRL) were goat anti-mouse
(dilution 1:1000) and goat anti-rabbit (dilution 1:1000). Goat anti-mouse
IgG was labeled with Alexa Fluor 488 dye and goat anti-rabbit IgG was
labeled with Alexa Fluor 546 dye. 4,6-Diamidino-2-phenylindole (DAPI,
5 lg/ml) from Sigma was used to label the nuclei for 10 min at 37 C. Cells
were then examined either by fluorescence microscope (Axiophot, Zeiss,
Germany) or by confocal microscope (LSM 510, Zeiss, Germany). The
insulinoma cell line INS IE was provided by C. Wollheim, Geneva,
Switzerland. HeLa cells were from ATCC (Manassas, VA).
Electron microscopy with immunogold labeling. Cells were fixed in a
mixture of 3% paraformaldehyde and 0.5% glutaraldehyde in 10 mM PBS,
pH 7.4, for 1 h. Cells were then washed in PBS and fixed in 0.5% osmi-
umtetroxide for 30 min. After rinsing with water, cells were dehydrated inethanol and embedded in LR White. Sixty nanometer-sections were
treated with 2% BSA in PBS to block non-specific bindings and incubated
with primary antibody in 2% BSA in PBS for 2 h. After rinsing with PBS,
the sections were incubated for 1 h with goat anti-rabbit IgG labeled with
10 nm gold particles (Amersham, Netherlands). The sections were washed
with PBS and water, stained with uranyl acetate and lead acetate and
observed and photographed in a LEO 910 TEM (Zeiss).
Flow cytometry analysis. Single cell suspension of undifferentiated
and differentiated BC11-BT NestGFP cells were sorted with FACScan
(Becton–Dickinson, Palo Alto, CA) based on GFP fluorescence. BC11-BT
cells were used as standard for cell size and aspect, and as negative control.Results and discussion
Isolation of single cell derived colonies
After few days of culture of purified human islets an out-
growth of cells with a fibroblast-like appearance was
observed. This was paralleled by the induction of several
stem cell markers including nestin, the side population stem
cell marker ABCG2, stem cell factor (SCF), c-Kit, and
Thy-1, a potential marker for liver stem cells [17]. During
the proliferation period, the levels of insulin and Ipf-1
mRNA expression gradually decreased, to become unde-
tectable at passage 7 (Fig. 1A). The transcription factor
Ipf-1 is crucial for initiation of pancreas development and
an important regulator of insulin transcription in adult life
[1]. Immunocytochemistry studies (ICC) showed that
almost all cells were positive for nestin (Fig. 1B). Assuming
that some of these cells may represent stem cells we subject-
ed the population (at passage 2) to single cell cloning by
FACS (Fig. 1C). Two weeks later, growing colonies were
observed in five of a total of 192 wells. All five colonies
continued to express ABCG2 and nestin but neither insulin
nor Ipf-1 (Fig. 2A). Interestingly, all colonies expressed the
transcription factor Isl-1 suggestive of mesenchymal stem/
progenitor cells (Fig. 2A). During development, both nes-
tin and Isl-1 are found in pancreatic mesenchyme sur-
rounding the epithelial cells that also express Isl-1 [2,3].
Isl-1 is well known for its critical role in the development
of pancreatic endocrine cells [2].
Immortalization of single cell derived colonies
Extensive functional characterization of progenitor/
stem cells requires stable and robust proliferation. For this
purpose, we immortalized the best growing clone (BC11)
by overexpressing telomerase alone or together with mBmi
via Lox-CRE excisable lentiviral vectors as described previ-
ously [8] (Fig. 2B–D). This combination of genes has been
shown to be optimal for immortalization of primary
human cells without genetic alterations [9]. Furthermore,
Bmi-1 was recently shown not only to promote cell cycling
but also to be crucial for the maintenance of the precursor
status of neuronal progenitors [18]. In an additional purifi-
cation step these cells were transduced with a lentivector
containing a nestin-GFP promoter construct. Cells with
the highest GFP levels were then selected based on the
Fig. 2. (A) Expression of mRNA for nestin, ABCG2, Isl-1, insulin, and IPF-1 in cultured human islets of Langerhans (passage 2) and single cell derived
colonies (BA1, SA1, BA3, BH10, and BC11). APRT mRNA expression served as positive control. The cells of origin as well as all colonies isolated
expressed nestin, ABCG2, and Isl-1 but only the original cell population was positive for insulin and IPF-1. Cultured islet cells are FGF2 and EGF
stimulated cells. (B–G) Clone BC11 was transduced with immortalizing HLOX lentiviral vectors and analyzed for proliferation and morphology. Passage
numbers and cell counts corresponding to phase contrast analysis were as follows: (B) untransduced cells, passage 4, 5.9 · 103 cells. (C) Cells transduced
with hTERT, passage 5, 2.3 · 104 cells; (D) cells transduced with mBmi-1 and hTERT, passage 5, 1.1 · 106 cells. Original magnification 200·. The BC11
cells immortalized with mBmi-1 and hTERT (BC11-BT) were then transduced with a lentiviral vector containing a tissue-specific nestin-GFP cassette
depicted in (E). (F) FACS analysis of immortalized BC11-BT after transduction with CX-NestGFP vector. Cells were analyzed by flow cytometry using
two channels: FL-1, green fluorescence for GFP signal, x-axis, 4-decade log scale; FL-2, red fluorescence for non-specific auto-fluorescence, y-axis,
4-decade log scale. Cells were gated for specific GFP signal (32% of viable cells in gate R2) and positively sorted for further culture. (G) GFP expression of
sorted nestin-GFP positive immortalized BC11-BT NestGFP cells. Sorted cells from (F) gate R2 were analyzed as in (F) after 3 weeks of culture and
expansion. The percentage indicates the fraction of cells in gate R2 (94% of viable cells in gate R2). (For interpretation of the references to color in this
figure legend, the reader is referred to the web version of this paper.)
Fig. 1. (A) Purified human islets express nestin, c-Kit, Thy-1 as well as the transcription factors Isl-1, Ipf-1, and also insulin but no ABCG2 and no SCF.
Cultured islets cells (passage 7) express nestin, ABCG2, Thy-1 as well as Isl-1 but no Ipf-1 and no insulin. (B) By immunocytochemistry more than 90% of
cells outgrowing from the islets at passage 2 were positive for nestin. Original magnification 200·. (C) Isolation of single cell derived colonies from cultured
human islet cells (passage 2) using a FACS procedure. After 10–14 days formation of proliferating colonies was observed in five of a total of 192 wells.
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Fig. 3. (A) Expression of mRNA for nestin, ABCG2, stem cell factor (SCF), c-Kit, and Thy-1 together with Isl-1 in all immortalized single cell derived cell
lines. Cultured islet cells passage 7, BC11-T denotes single cell derived cells immortalized by induction of telomerase only; BC11-BT immortalized by
induction of telomerase and mBmi; BC11-BT NestGFP indicates BC11-BT additionally purified for nestin-expressing cells. (B) Immunocytochemistry for
Isl-1 expression shown in immortalized BC11-BT cells. Note the nuclear staining for the transcription factor Isl-1 in immortalized BC11 cells as well as in
the rat insulinoma cell line INS 1E that served as positive control. HeLa cells were not Isl-1 positive. Nuclear staining was performed with DAPI. Original
magnification 200·. (C) Immortalized cell lines (up to 75 passages) have maintained their phenotype without evidence for chromosomal aberrations.
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ed with enhanced stem cell potential (Fig. 2E–G). The
resulting immortalized clones continued to express the stem
cell markers nestin, ABCG2, SCF, c-Kit, and Thy-1 and
the transcription factor Isl-1 (Fig. 3A), the latter detected
in almost all cells by ICC (Fig. 3B). These immortalized
cells have been cultured for up to 75 passages while main-
taining their phenotype without evidence for chromosomal
aberrations (Fig. 3C).
Differentiation of immortalized cells into pancreatic
endocrine phenotype
To induce differentiation into a pancreatic endocrine
phenotype cells were cultured in serum-free DMEM/F12
medium supplemented with factors known for their benefi-
cial effects on differentiation of precursors into insulin pro-
ducing cells such as exendin-4, nicotinamide, hepatocyte
growth factor, activin-A, and pentagastrin [19–22]. During
the 4 days of incubation in ultra-low attachment tissue cul-
ture dishes, we observed the formation of islet-like clusters
(Fig. 4A) and the induction of transcription factors known
for their pivotal role during development of pancreatic
endocrine cells including Isl-1, Ipf-1, Ngn3, Pax4, Pax6,Nkx2.2, and Nkx6.1 (Fig. 4B). In addition, insulin, gluca-
gon and somatostatin mRNAs were up-regulated
(Fig. 4B) while GFP expression decreased in parallel in
the NestGFP-transduced BC11-cells (Fig. 4C–E). All
immortalized cell lines gave very similar results regarding
their differentiation potential. Interestingly, Pax-4, Pax-6,
glucagon, and somatostatin were already expressed, albeit
at a lower level, before induction of differentiation. Using
confocal microscopy we could identify C-peptide positive
cells in some areas of differentiated islet-like clusters
(Fig. 5A). C-peptide is part of the proinsulin peptide and
thus an indicator of de novo proinsulin production. Gluca-
gon positive cells were also identified at the periphery of
islet-like cluster (Fig. 5A). Electron microscopy combined
with immunogold staining revealed C-peptide positive
granula in differentiated cells (Fig. 5B). These data are in
agreement with previous reports showing the generation
of insulin producing cells from cultured nestin positive cells
from fetal human pancreas [6,7]. Our results however
contrast with studies in which purified nestin-expressing
cells isolated from human fetal pancreas were not able to
adopt a pancreatic endocrine phenotype in vitro or in vivo
[23]. Beside the differences in cell type, fetal pancreatic
versus immortalized adult islet derived cells, this apparent
Fig. 4. (A,B) Differentiation of immortalized cells into an endocrine phenotype. (A) After 4 days of culture in differentiation medium, the cells formed
islet-like clusters (phase contrast image). (B) Expression of transcription factors known to play an important role in pancreatic endocrine formation
including Ipf-1, Isl-1, Ngn3, Pax4, Pax6, Nkx2.2, and Nkx6.1 as well as the mRNA transcripts of the islet hormones insulin, glucagon, and somatostatin
(data shown with BC11-BT NestGFP cells). (C–E) Nestin-GFP reporter activity during differentiation. Cells were analyzed by FACS for size (FSC) and
aspect (SSC). The FSC vs. SSC 2-D plots were used to set a gate (R1) containing viable cells of similar size for each conditions for further fluorescence
analysis. R1-gated cells were then analyzed for GFP fluorescence (FL1, x-axis, 4-decade log scale) and autofluorescence (FL2, y-axis, 4-decade log scale,
lower panel). The percentage and mean of fluorescence intensity were determined in the R2 gate, containing only GFP-expressing cells. BC11-BT cells
without NestGFP construct were used as standard for cell size and aspect and as negative control for GFP expression. (C) GFP positive cells before
differentiation: 96% (D); GFP positive cells after differentiation: 44% (E).
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the differences in culture conditions. As positive control in
their studies Humphrey et al. [23] used cultured islet-like
cluster from fetal human pancreas. These clusters most
likely included already advanced precursors that may
require other culture conditions than selected nestin posi-
tive cells that failed to differentiate into an endocrine phe-
notype [23]. Our differentiation medium contains a cocktail
of factors known for their beneficial effect on differentia-
tion of precursors into insulin producing cells [19–22].Moreover, very similar results were obtained when human
mesenchymal stem cells from adipose tissue [24] or bone
marrow (data not shown, manuscript submitted) were
induced to adopt a pancreatic endocrine phenotype.
Differentiation into a hepatic phenotype in vivo
Pancreatic stem or progenitor cells have been shown to
adopt a hepatic phenotype in vitro [5] or in vivo [15,25]
suggesting the presence of a common hepato-pancreatic
Fig. 5. (A) Immunofluorescence staining of differentiated BC11 cells. Islet-like clusters were stained with anti-C-peptide or glucagon antibody. Nuclei
staining was performed with DAPI. Images were obtained with a laser scanning confocal microscope (Zeiss LSM 510). Original magnification 200· for
C-peptide image and, 400· for glucagon. (B) Electron microscopy studies revealed formation of granules in differentiated cells in contrast to
undifferentiated cells. Red arrows indicate immunogold labeling for C-peptide (inset). (For interpretation of the references to color in this figure legend, the
reader is referred to the web version of this paper.)
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immortalized cells to differentiate into a hepatic phenotype
BC11 NestGFP cells were injected directly into the liver of
SCID mice. Thirty-five days later human albumin positive
cells were found in the livers of three out of 8 transplantedFig. 6. (A,B) Adoption of a hepatic phenotype in vivo. (A) Thirty-five days a
mouse liver, immunohistochemistry studies were performed using a monoclona
as negative and human liver as positive control. Original magnification 100·
transplantation of immortalized BC11-BT NestGFP cells (TL). Human liver
negative control. (C,D) Differentiation into adipocytes. (C) After culturing for
cells formed fat droplets as visualized by Oil Red staining. Nuclear staining w
adipocyte-specific genes PPARc2, adiponectin, and leptin in differentiated cells
cells (not shown). Mesenchymal stem cell derived adipocytes were used as posanimals (Fig. 6A), indicating that immortalized BC11
NestGFP cells have the potential to acquire a hepatocyte-
like phenotype in vivo. RT-PCR studies confirmed the
expression of human albumin transcripts in grafted livers
(Fig. 6B). Interestingly, it has been reported recently thatfter transplantation of immortalized BC11-BT NestGFP cells into SCID
l antibody specific for human albumin. Normal SCID mouse liver was used
. (B) Detection of human albumin transcript in SCID mouse liver after
(HL) was used as positive control. SCID mouse liver (ML) was used as
2–3 weeks in adipogenic differentiation medium, immortalized BC11-BT
as performed with DAPI. Original magnification 400·. (D) Expression of
. The adipocyte-specific genes are not expressed by cultured immortalized
itive control (M).
Fig. 7. Differentiation into an osteoblast-like phenotype. (A) Alkaline phosphatase (AP) activity increases during culture of immortalized BC11-BT
NestGFP cells in osteogenic medium (OM) reaching levels comparable to those expressed by bone marrow derived mesenchymal stem cells (BMSC).
(B) AP positive cells were stained in blue. Original magnification 400·. (C) The BC11-BT NestGFP cells formed foci of mineralization visualized by
Alizarin Red after 3 weeks’ culture in OM. BMSC cultured in OM were used as positive control, BC11-BT NestGFP cultured without OM were used as
negative control. Original magnification 100·. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of
this paper.)
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xenografted directly into rat liver differentiate into human
hepatocytes without evidence for fusion [26]. Thus, adop-
tion of a hepatic phenotype in vivo may be a property of
mesenchymal stem cells.
Differentiation into adipocytic and osteoblastic phenotypes
Supposing that the immortalized BC11 cells may have a
mesenchymal phenotype, we next tried to direct the differ-
entiation into an adipocytic or osteoblastic phenotype
using culture conditions normally applied for differentia-
tion of bone marrow derived mesenchymal stem cells or
preadipocytes [13,14,16,27]. After 2–3 weeks in adipogenic
medium, appearance of fat droplets was observed and par-
alleled with expression of adipocyte specific genes like
PPARc2, leptin, and adiponectin (Fig. 6C and D). After
3 weeks in osteogenic medium [16], immortalized BC11
cells became positive for alkaline phosphatase and deposit-
ed mineralized matrix as shown with the Alizarin staining
(Fig. 7A–C).
In our primary islet cell culture the appearance of nestin-
expressing cells is most likely the result of FGF2- and
EGF-stimulated proliferation of precursor cells that were
already present in adult islets of Langerhans. As well, they
could derive from bone marrow and belong to a pool of
circulating stem cells [28]. Noteworthy, mesenchymal
stem/precursor cells from bone marrow [29,30] have been
shown to differentiate into insulin-expressing cells in vitro
and in vivo [30,31]. Stem cells with a mesenchymal pheno-
type have been also shown to arise in human islet cultures
by de-differentiation of epithelial b-cells induced by growthfactors like EGF [32]. The islet derived mesenchymal cells
expressed nestin and vimentin and were able to re-differen-
tiate into insulin-expressing cells given the appropriate
stimuli [32]. A similar de-differentiation of human islet cells
in vitro was also suggested in a recent study although the
authors described a de-differentiation into a pancreatic
ductal rather than mesenchymal phenotype [33].
The mesenchymal origin of our nestin and Isl-1 positive
cells may explain that cell lineage studies did not show pan-
creatic b-cells originating directly from nestin-expressing
cells during development [23,34–36]. But, these studies do
not exclude the differentiation of mesenchymal stem cells
in insulin producing cells in vitro or in vivo, as shown by
the present and previous reports [5,6,20,31,37]. As a limita-
tion of our study the immortalized BC11cells were not yet
able to secret insulin in response to high glucose indicating
a certain level of developmental immaturity. However, the
evidence that these cells can be immortalized with a pre-
served differentiation potential and without noticeable
karyotypic changes, thus probably providing virtually
unlimited supplies of insulin producing cells, opens new
opportunities for the search of stem cell based therapies
of diabetes mellitus.
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Introduction
During embryogenesis, progenitor cells of pancreas and liver
emerge from neighboring areas of the gut endoderm [1].
There is a large body of evidence suggesting that such pro-
genitors with the potential to generate liver cells from pan-
creatic cells and vice versa may still exist in adult life [2–5].
Using the model of mice with a knockout of the tyrosine cata-
bolic enzyme fumarylacetoacetate hydrolase (FAH), which,
without treatment, results in liver cirrhosis, Wang et al. [6]
succeeded in correction of liver function by transplantation
of cell suspensions from adult pancreas of wild-type animals.
With this unique repopulation assay, the authors clearly
demonstrated that progenitor cells with the ability not only to
replace FAH knockout cells in the liver but also to correct the
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derived progenitor cells that did not express albumin in
vitro were stained with the red fluorescent dye PKH26
and injected into the liver of severe combined immunode-
ficiency mice. After 3 or 12 weeks, red fluorescent cells
were detected in 11 of 15 livers and were mostly single
cells that were well integrated into the liver tissue.
Human albumin was found in 8 of 11 animals by
immunohistochemistry, and human albumin mRNA was
detected in 4 of 10 host livers. The mechanism underlying
this phenomenon seems to be transdifferentiation,
because human and mouse albumin were found to be
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liver function exist in the pancreas, although the exact nature
of these cells remains unknown. Interestingly, cells from cul-
tured pancreatic ducts were not able to rescue the failing liver
as did the crude pancreatic cell suspension [6], indicating
that the presumed hepatopancreatic stem cells reside in areas
outside the pancreatic ducts.
Numerous studies have shown the transdifferentiation
potential of pancreatic cells of rodents into hepatocytes in
vivo. Some very rare cases of human pancreatic cancer with
hepatoid phenotype indicated the existence of similar cells in
human pancreas [7]. Recently, progenitor cells have been
described in rodent and human islets of Langerhans that
express the neural stem cell marker nestin [8] and the side-
population phenotype marker ABCG2 [9]. The side-popula-
tion cells in bone marrow represent a particularly potent stem
cell population [10]. Interestingly, the human nestin-
expressing islet-derived progenitor (NIP) cells were able to
adopt a hepatic phenotype in vitro with expression of mark-
ers like alpha feto protein and the transcription factor XBP
[8]. In contrast to animal data, however, no in vivo studies
have been published so far demonstrating transdifferentia-
tion of human pancreatic cells into a hepatic phenotype.
Recently, in vivo models for transplantation of human cord
blood cells into severe combined immunodeficiency (SCID)
mouse liver have been established [11, 12]. Using the model
with direct injection of cells into the liver, we demonstrate in
the present report that human cells from cultured pancreatic
islets of Langerhans engraft into SCID mouse liver and form
cells expressing human albumin in vivo.
Materials and Methods
Highly purified human islets are donations from the islet
transplantation center in Geneva, Switzerland (Drs. José
Oberholzer and Thierry Berney). Growth and expansion of
nestin-positive cells were induced by RPMI-1640 medium
with 10% fetal calf serum and supplemented with basic
fibroblast growth factor and epidermal growth factor (20
ng/ml of each). Nestin-positive cells were characterized by
reverse transcription–polymerase chain reaction (RT-PCR)
and immunocytochemistry. More than 90% of cells were
nestin positive. They were cultured for 4 months in the
expansion medium, which was changed every 3–5 days.
Trypsinization and reseeding were performed every 10–14
days. All experiments were done with cells of passage 4
through 9. Before transplantation, NIP cells were harvested
by trypsinization, washed twice with phosphate-buffered
saline (PBS), and stained with the red fluorescent dye
PKH26 (Sigma) according to the staining protocol of the
supplier (Sigma). The concentration of PKH26 during incu-
bation with NIP cells was 4 µM. Incubation was performed
for 4 minutes at 25°C with 107 NIP cells per ml. William’s E
medium with 1% bovine serum albumin (BSA) was used to
stop the staining reaction. All centrifugation and washing
steps during the staining procedure were performed at room
temperature. Afterward, the NIP cells were resuspended in
PBS at a concentration of 1.5  104 cells, 1.5  105, and 7.5 
105 per 100 µl (Table 1).
The transplantation protocol was approved by the Animal
Care and Use Committee in Rheinland-Pfalz, Germany.
SCID mice (age, 6–20 weeks; weight, 18–27 g) were obtained
from Charles-River (Sulzfeld, Germany). They were fed a
standard diet purchased from Sniff (Soest, Germany) and
acidified drinking water ad libitum. Before transplantation,
mice were anaesthetized by intraperitoneal injection of 61.5
mg/kg ketamine (ketamin-ratiopharm 50, Ratiopharm, Ulm,
Germany) and 2.3 mg/kg xylazine (Rompun 2%, Bayer, Lev-
erkusen, Germany). Ketamine and xylazine were combined
immediately before administration. The peritoneal cavity was
opened directly below the xiphoid cartilage, and the NIP cells
were slowly (100 µl in approximately 60 seconds) injected
into the parenchyma of the protruding liver lobe using a 26-
gauge needle (0.45  25, Henke-Sass, Tuttlingen, Germany).
Immediately before injection, the cell suspension was
warmed to 37°C. Successful injection was approved by a
short-term paleness of the liver lobe. Previously, negative
findings regarding fluorescence signals, RT-PCR, and
immunohistochemistry (see below) have been observed after
injection of human mononuclear cells as controls [11].
Three or 12 weeks after transplantation (Table 1), SCID
mice were killed by neck dislocation, and after opening the
peritoneal cavity, the protruding liver lobe that received the
injection was excised. This liver lobe was divided into three
parts. One part was fixed in 4% paraformaldehyde for
immunohistochemical analysis, and two parts were shock
frozen in liquid nitrogen for RNA isolation and fluorescence
microscopy. Using a cryotome (CM 3000 cryostat, Leica
Instruments GmbH, Nussloch, Germany), 5-µm-thick
cryosections were produced. Cryosections were transferred
onto Super-Frost Plus slides (Menzel, Braunschweig, Ger-
many), air dried, and immediately analyzed by fluorescence
microscopy using a standard filter setup for visualization of
PKH26.
For immunohistochemistry, peroxidase was blocked in
7.5% H2O2 in methanol for 60 minutes at 4°C. Unspecific
binding sites were blocked in 3% BSA for 2.5 hours at 37°C.
Afterward, an avidin/biotin-block (Vector Laboratories,
Burlingame, CA) was performed as described by the manu-
facturer. Slides were then incubated with a 1:50 dilution of an
affinity purified human albumin antibody produced in goat
(Bethyl Laboratories, Montgomery, TX; catalogue No. A80-
229A) for 60 minutes at room temperature. Detection of first
antibody was performed using commercial Vectastain Elite
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ABC Kit (Vector Laboratories) as described by the manufac-
turer, followed by a 5-minute incubation with 0.6 mg/mL
diaminobenzidine at room temperature. Finally, the sections
were counterstained with a 1:5 dilution of Mayer’s hemalum
(Merck, Darmstadt, Germany).
For fluorescence-immunohistochemistry (confocal
microscopy, 630-fold magnification), human albumin was
detected using a polyclonal anti-human albumin antibody
raised in rabbit (Abcam Ltd.) in a 1:500 dilution. Detection
of the primary antibody was performed using a Cy3-labeled
secondary antibody against rabbit, raised in donkey
(Dianova GmbH) in a 1:1000 dilution. Counterstaining was
done using 4',6'-diamidino-2-phenylindole (DAPI) (Molec-
ular Probes) at a concentration of 2.3 µg/1,000 µL. Mouse
albumin was detected using a polyclonal fluorescein isothio-
cyanate–labeled anti-mouse albumin antibody raised in goat
(Bethyl Ltd.) in a 1:25 dilution. Counterstaining was done
using DAPI (Molecular Probes) at a concentration of 2.3
µg/1,000µL. A digital overlay was performed of Figures 2B
and 2C.
For RT-PCR, homogenization of liver samples was per-
formed by a polytron homogenizer, and total RNA was iso-
lated using RNeasy Midi Kit (Qiagen, Hombrechtikon,
Switzerland). Total RNA, 1 µg, was subjected to RT-PCR
using Omniscript and Taq PCR core kit (Qiagen). Negative
controls without reverse transcriptase enzyme were run in
parallel to exclude possible contamination. C-DNA was
amplified for 38 cycles (94°C for 30 seconds; annealing tem-
perature 60°C for 60 seconds; 72°C for 60 seconds) using the
following human-specific, intron-spanning primers: albu-
min forward ACTTTTATGCCCCGGAACTC and reverse
AGCAGCAGCACGACAGAGTA,ABCG2 forward CACA
GGTGGAGGCAAATCTT and reverse TCCAGACACAC-
CACGGATAA, SCF forward GGTGGCAAATCTTCCAA
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Table 1. Detection of donor-derived cells after transplantation of islet-derived progenitor cells into severe combined immunodefi-
ciency mouse livers
Human albumin:
Number Time before Red immunohistochemistry
Fluorescence of cells excision fluorescent reverse transcription–
Mouse number marker transplanted of livers cells polymerase chain reaction
1 PKH26 15,000 —a — — —
2 PKH26 15,000 3 weeks Negative — —
3 PKH26 15,000 3 weeks Negative — —
4 PKH26 15,000 3 weeks Negative — —
5 PKH26 15,000 12 weeks Negative — —
6 PKH26 15,000 12 weeks Negative — —
7 PKH26 15,000 12 weeks Negative — —
8 PKH26 150,000 3 weeks Positive — —
9 PKH26 150,000 3 weeks Positive — —
10 PKH26 150,000 12 weeks Negative — —
11 PKH26 150,000 12 weeks Positive — —
12 PKH26 150,000 3 weeks Positive Positive Positive
13 PKH26 150,000 3 weeks Negative Negative Negative
14 PKH26 150,000 3 weeks Positive Negative Negative
15 PKH26 150,000 3 weeks Positive Positive Positive
16 PKH26 150,000 3 weeks Negative Negative Negative
17 PKH26 150,000 3 weeks Positive Positive Negative
18 PKH26 750,000 3 weeks Positive Positive Positive
19 PKH26 750,000 —a — — —
20 — 150,000 3 weeks — Positive Negative
21 — 150,000 3 weeks — Positive Negative
22 — 750,000 3 weeks — Positive Positive 
23 — 750,000 3 weeks — Positive —
aMouse died immediately after the operation.
AU5
AAG and reverse TCTTTCACGCACTCCACAAG, c-Kit
forward GGCATCACGGTGACTTCAAT and reverse GGT
TTGGGGAATGCTTCATA, Thy-1 forward GTCCTTTC
TCCCCCAATCTC and reverse GGGAGACCTGCAAGAC
TGTT, IPF-1 forward CCTTTCCCATGGATGAAGTC and
reverse TTGTCCTCCTCCTTTTTCCA, insulin forward
CTACCTAGTGTGCGGGGAAC and reverse GCTGGTA
GAGGGAGCAGATG, CD45 forward CAGGCAGCAAT
GCTATCTCA and reverse CTGTGATGGTGGTGTTG-
GAG, and adenine phosphoribosyltransferase (APRT) for-
ward GCGTGGTATTCAGGGACATC and reverse CAGGG
CGTCTTTCTGAATCT. Identity of the amplified PCR pro-
duct was confirmed by sequencing.
Normal human metaphase spreads were prepared from
approximately 70% confluent NIP cells in a T25 culture flask
by addition of 20 µl colcemid (10 µg/ml, KaryoMax, Gibco-
BRL) and incubation for 1.5 hours. Cells were then trypsi-
nized, pelleted, and resuspended in hypotonic solution (KCl-
Na-citrate). After fixation with methanol/acetic acid (3:1),
typsin/giemsa G-banding was performed according to stan-
dard laboratory procedures. Slides were examined with a
ZEISS-Axiophot (Zeiss), and images were taken using a
CCD camera (Cohu) and specially designed software (Kary-
otech 2000).
Results
NIP cells expressed beside nestin also the side-population
marker ABCG2 as well as SCF, c-Kit, and Thy-1, another
potential marker for hepatic stem/progenitor cells (Fig. 1A).
These cells were negative for expression of the transcription
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Figure 1. (A): NIP cells not only express the neural stem cell marker nestin but also the side-population marker ABCG2, SCF, c-Kit,
and the hepatic stem cell marker Thy-1. NIP cells did not express IPF-1 or insulin. The human housekeeping gene APRT was used as
positive control for RT-PCR. (B): Lack of CD45 expression in NIP cells with positive signal in human cord blood cells. (C): Detection
of human albumin in SCID mouse liver after transplantation of NIP cells. RT-PCR analysis shows the expression of human albumin
mRNA in transplanted SCID mouse number 18. Human albumin is not expressed by cultured NIP cells. HepG2 cells were used as posi-
tive control. SCID mouse liver was used as negative control. The origin of all PCR products was confirmed by sequencing. Abbrevia-
tions: APRT, adenine phosphoribosyltransferase; NIP, nestin-expressing islet-derived progenitor; RT-PCR, reverse transcription–
polymerase chain reaction; SCID, severe combined immunodeficiency.
factor IPF-1 and insulin but also the specific marker for
hematopoietic cells CD45 (Fig. 1B). Before transplantation,
no albumin expression was found in cultured NIP cells (Fig.
1C). To exclude numerical or structural chromosomal aber-
ration due to prolonged growth stimulation in vitro, a kary-
otyping was performed and revealed a normal 46,XX kary-
otype (Fig. 2).
Transplantation of 1.5  104 human NIP cells failed to
result in detectable red fluorescent cells that became
detectable only after transplantation of 1.5  105 cells in three
of four animals (Table 1). We next evaluated the impact of
time after transplantation on engraftment frequency and
found similar results 3 and 12 weeks after transplantation.
Cells expressing human albumin were found in liver sections
of 8 out of 11 animals. The cells were well integrated into the
liver tissue and were predominantly found adjacent to vascu-
lar structures (Fig. 3). Transplantation of NIP cells without
prior tagging with PKH26 seemed to be more successful and
resulted in detection of human albumin-positive cells in all
four grafted animals. To analyze fusion as a possible mecha-
nism underlying this phenomenon, immunohistochemistry
studies were performed using mouse-specific and human-
specific anti-albumin antibodies. In case of fusion, we
expected both types of albumin to be expressed in the grafted
cell. Using confocal microscopy, expression of human and
mouse albumin was found in distinct cells, suggesting that
NIP cells did adopt a hepatic phenotype by differentiation
induced by surrounding liver tissue rather than fusion (Fig.
4). Additionally, RT-PCR was performed, demonstrating the
presence of human albumin mRNA in 4 of 10 animals (Fig.
1C). In the four human albumin–positive livers, the human
APRT was also amplified using RT-PCR, although the signal
was less abundant than albumin (data not shown). No
mononuclear cell infiltration associated with human albu-
min–positive cells and no neoplasm were observed 3 and 12
weeks after transplantation. In our model, the occurrence of
human albumin–positive cells in general, however, was a
rare event, with detection of one to three positive cells on
every second slice.
Discussion
Adoption of a hepatic phenotype by human NIP cells has been
previously described in vitro [8], suggesting that these cells
may represent a common hepatopancreatic precursor. In the
present study, we show for the first time that cultured NIP
cells from human islets of Langerhans express human albu-
min in vivo when transplanted into SCID mouse liver. During
the expansion period, these cells were negative for the albu-
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Figure 2. GTG banded metaphase of a nestin-positive cell showing an intact 46,XX karyotype. 
min transcript and thus acquired this phenotype after injection
into the liver only. The immunohistochemistry results clearly
show the expression of human albumin after transplantation
and demonstrate that these cells are well integrated into the
host liver tissue (Fig. 3), although it was in general a rare
event, with one to three cells every second slice. The human
albumin–positive cells were found mostly as scattered single
cells, with rarely also formation of small clusters. Interest-
ingly, we found more human albumin–positive cells after
transplantation without labeling with PKH26, probably
because of its known cytotoxic effect [13]. The dose-finding
experiment showed that at least 1.5  105 injected cells are
required for detection of human albumin–positive cells, and
the best results were obtained with 7.5  105 cells, in which
human albumin–expressing cells were found in all recipient
livers. Interestingly, many of the scattered cells were found
adjacent to vascular structures (Fig. 3), as already described
by Newsome et al. [12] in their study with infused human cord
blood cells. In their report, the appearance of human albu-
min–positive cells in general was a rare event, with similar
efficiency after 4, 6, or 16 weeks [12]. Likewise, we have seen
very similar results 3 and 12 weeks after transplantation,
although we did not quantify the real transplantation effi-
ciency in this proof-of-principle study. The RT-PCR studies
confirmed the immunohistochemistry results in some but not
all animals (Fig.1, Table 1). This may be because of the enor-
mous dilution of human mRNA with mouse mRNA in the RT
process. The appearance of human albumin–positive cells in
the transplanted livers does not necessarily indicate fully
functioning hepatocytes, although albumin is the most char-
acteristic protein synthesized by mature liver, accounting for
more than 10% of total protein synthesis and the most abun-
dant transcript in hepatocytes [14].
In the elegant studies by Wang et al. [6], a repopulation
assay of FAH-deficient animals was used as a gold standard
to determine the replacement of liver function by pancreatic
stem/progenitor cells in the failing organ. This type of experi-
ment, however, is not yet feasible for studies with human
cells using SCID mice as recipients.
The mechanism underlying the adoption of a hepatic
phenotype by grafted human NIP cells seems to be transdif-
ferentiation rather than fusion, because expression of mouse
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Figure 3. Immunohistochemistry 3 weeks after transplantation of human islet-derived progenitor cells into SCID mouse liver using a
monoclonal antibody specific for human albumin and diaminobenzidine (brown) for staining (A), nontransplanted SCID mouse liver
as negative control (B), and human liver (C) as positive control (bar = 20 µm). Note the proximity of grafted cells to vascular structures. 
and human albumin was found in distinct cells (Fig. 4). In a
fused cell, we would expect to find expression of mouse and
human albumin in the same cell. Fusion, however, cannot be
excluded based on these findings alone, although it seems
less likely. In particular, we cannot rule out that fusion was
indeed the initial event, followed by reduction division,
which restored the cell to its normal (in our case human)
diploid state with expression of human albumin only. Reduc-
tion division after fusion has been described for hematopoi-
etic cells that fused with hepatocytes [15]. An increasing
number of most recent reports demonstrates that cell fusion
is a common phenomenon when hematopoietic stem cells
engraft into liver tissue [15, 16] and in the central nervous
system [17]. Moreover, fusion of human hematopoietic stem
cells that were injected in utero in swine were shown to yield
transdifferentiation and retroviral transfer among species
[18], indicating that fusion of stem cells may be a common
phenomenon in vivo. However, transdifferentiation of hema-
topoietic stem cells into hepatocytes without evidence for
fusion was also reported recently [12]. Cell fusion in vivo 
has been described for hematopoietic stem cells but not 
pancreatic stem cells. The NIP cells used in our study were
negative for the specific marker for hematopoietic cells
CD45 (Fig. 1B).
Recently, human nestin-positive islet-derived progenitor
cells have been shown to engraft into many tissues, including
the liver, of immunocompetent mice [19] without rejection,
although the investigators did not analyze the expression of
tissue-specific genes of human origin. This remarkable
study, however, stresses a particular characteristic of NIP
cells as stem/progenitor cells that are not rejected in a xeno-
transplantation setting [19].
In the present study, expression of human albumin in
SCID mouse liver after transplantation of NIP cells is another
important in vivo proof for the stem cell potential of these
cells.
1140 Human Islet-Derived Progenitor Cells
Figure 4. Fluorescence-immunohistochemistry with human and mouse specific antibodies against albumin using confocal
microscopy with 630-fold magnification. (A): One cell stained with antibodies against human albumin. (B): The same cell with addi-
tional 4',6'-diamidino-2-phenylindole staining for cell nuclei. (C):Albumin staining with antibodies against mouse albumin. (D): Dig-
ital overlay of human and mouse albumin staining showing no costaining for mouse albumin in the human albumin-positive cell.
Summary
Human islet-derived stem cells are capable of adopting 
a hepatic phenotype in a SCID mouse liver in vivo, suggest-
ing the presence of a hepatopancreatic stem/progenitor 
cell within or adjacent to the islets of Langerhans. The
mechanism underlying this phenomenon seems to be trans-
differentiation, although fusion with host hepatocyte cannot
be completely ruled out. In the context of these recent find-
ings, one could envision new therapeutic avenues for the
treatment of liver cirrhosis using human pancreatic stem/
progenitor cells in which such cells could be isolated from
pancreatic biopsies and expanded in vitro before trans
plantation.
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Abstract  
Replacement of insulin producing cells represents an almost ideal treatment 
for patients with diabetes mellitus type 1. Here we show that human bone 
marrow-derived mesenchymal stem cells (MSC) harbour the potential to 
differentiate into insulin, glucagon and somatostatin expressing cells in vitro. 
MSC from 5 healthy donors and 3 patients with diabetes type 1 were 
expanded and differentiated using defined culture conditions. Upon 
differentiation we observed the expression of various pancreatic genes 
including the transcription factors Isl-1, Ipf-1, Ngn-3, Pax-4, Pax-6, Nkx-2.2 
and Nkx-6.1 as well as the islet proteins insulin, glucagon, somatostatin and 
the glucose transporter glut-2.    
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Introduction 
Stem/progenitor cells with the potential to differentiate into insulin 
expressing cells were described in pancreatic ducts [1], islets of Langerhans 
[2,3], the liver [4,5], the central nervous system [6], the spleen [7] and bone 
marrow [8,9]. Mesenchymal stem cells (MSC) from mouse bone marrow were 
shown to harbour the potential to differentiate into insulin secreting cells in 
vitro and to reverse hyperglycaemia in an animal model of diabetes [9]. 
Similarly, mesenchymal precursor cells from mouse spleen were able to 
regenerate insulin producing cells in a mouse model of autoimmune diabetes 
[7]. Recently human MSC were described to express at low level the islet 
transcription factor Nkx-6.1 and to differentiate into insulin producing cells 
upon adenoviral transduction with vectors over-expressing the transcription 
factors Ipf-1, Hlxb-9 or Foxa-2 [10]. The mechanisms underlying this apparent 
developmental plasticity of MSC are unknown. Interestingly, MSC were also 
shown to bear the potential to adopt a neural phenotype in vitro and in vivo 
[11-14] in rodents and humans [13] suggesting a neuro-endocrine 
developmental capacity of these cells. Expanding MSC express several stem 
cell marker like stem cell factor (SCF) and Thy-1 [15,16] but also nestin 
[13,14,17], a gene initially characterized as a marker of neural stem or 
progenitor cells [18] and later also suggested to be a marker for multipotent 
pancreatic stem cells [3]. Neural precursor cells express beside nestin also the 
side population stem cell marker ABCG2 [19,20]. Nestin and possibly ABCG2 
expression could therefore represent a possible link between MSC and their 
ability to differentiate into neuro-endocrine cells. ABCG2 expression was not 
yet described in human bone marrow derived MSC.   
Stem/progenitor cells with the capacity to adopt a pancreatic endocrine 
phenotype should follow at least in part the complex program of normal 
pancreas development, for review see [21]. Initiation of pancreas development 
requires the induction of the transcription factor Ipf-1 that is prerequisite for 
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pancreas formation in mouse and man [22,23]. Shortly thereafter the 
transcription factor islet-1 (Isl-1) that is required for generation of endocrine 
cells is induced at day E9 [24] followed by induction of the transcription 
factor Ngn-3, another crucial step toward pancreatic endocrine cells [25,26]. In 
the present study we show that MSC from human bone marrow of non-
diabetic subjects as well as patients with longstanding type 1 diabetes are 
positive for the stem cell markers nestin and ABCG2 and display the potential 
to activate pancreatic developmental genes in response to defined culture 
conditions. This includes the transcription factors Ipf-1, Isl-1, Ngn-3, Pax-4, 
Pax-6, Nkx-2.2, Nkx-6.1 as well as the islet genes insulin, glucagon, 
somatostatin and glut-2. 
 
Research design and Methods 
Isolation and expansion of MSC 
Five non-diabetic subjects (age 26 to 64 years) referred to the University 
Hospital for routine orthopaedic surgery were asked to donate 20 ml bone 
marrow during the surgical procedure. Three consecutive c-peptide negative 
patients (age 31, 50 and 53 years) with diabetes mellitus type 1 for 14, 35, and 
37 years, respectively donated 20 ml bone marrow that was obtained by 
aspiration biopsy. All patients gave informed written consent and the study 
protocol was approved by the local ethics committee for human studies.  
  
After diluting the marrow aspirates with phosphate buffer saline (PBS) at a 
ratio of 1:4, nucleated cells were isolated using a density gradient solution 
(Histopaque, Sigma Chemical, Buchs, CH). The cells were cultured in 
Minimum Essential Medium (MEM) α medium with 5.5 mM glucose 
containing 10% heat inactivated fetal bovine serum (FBS), 1% HEPES (1M), 
1% sodium pyruvate MEM 100 mM, 1% penicillin-streptomycin glutamin 
(catalogue number 10378016  from Invitrogen AG, Basel, CH). Nucleated cells 
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were plated at a density of 100,000 cells/cm2 in the medium supplemented 
with 5 ng/mL fibroblast growth factor-2 (FGF, R&D Systems, Wiesbaden, 
Germany) and cultured in a humidified incubator at 37°C, 5% CO2. FGF was 
supplemented in order to enrich the fraction of true progenitor cells and to 
prevent spontaneous differentiation [27]. Medium was changed twice a week. 
Upon reaching 70-80% confluency, MSC were detached using 0.05% trypsin/ 
0.53mM EDTA and replated in culture dishes at a density of 103 cells /cm2 
MSC until subconfluency. MSC were then subcultured until the 3rd passage, 
for a total of 16 to 19 doublings and at an average rate of 0.81 ± 0.07 
doublings/day. The described protocol, consistent with most literature in the 
field, allows to obtain a population of cells negative for the haematopoietic 
markers CD45, CD14 and CD34 and uniformly positive for the mesenchymal 
markers CD90, CD44, CD105 and CD166 (data not shown).   
 
MSC culture 
After the 3rd passage medium was changed to DMEM with glucose 25 mM 
(Invitrogen, catalogue number 11971-025) supplemented with 10% heat 
inactivated FBS, 5 ng/mL FGF, 1% sodium pyruvate MEM 100 mM and 1% 
penicillin/streptomycin 5000 U/mL (all from Invitrogen AG, Basel, CH). 
Media and supplements were changed every 72 h. At a confluency of 95%, 
cells were collected using trypsin (Invitrogen AG, Basel, Switzerland) and 
washed twice with serum-free DMEM/F12 medium. 
For induction of differentiation, MSC were replated at a cell density of 2-3 x 
105/well and cultured for 3 days in ultra low attachment 6 well plates (Vitaris 
AG, Baar, Switzerland) allowing the formation of islet-like clusters. MSC from 
non-diabetic subject 1 were analyzed on two occasions, at passage 4 and 
passage 7. The gene expression profile of each differentiation study was 
analyzed every 24 hours for 3 days in every subject or patient. For each 
differentiation day cells from 4 separate wells were harvested and analyzed 
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independently and a mean value was calculated. Differentiation medium 
consists of serum-free DMEM/F12 medium with 17.5 mM glucose in the 
presence of  nicotinamide 10mM, activin-A 2 nM, exendin-4 10nM, hepatocyte 
growth factor 100 pM and pentagastrin 10 nM (all from Sigma, Basel, 
Switzerland, except for Pentagastrin that was from Cambridge Laboratories, 
Newcastle Upon Tyne, UK) as well as B-27 serum-free supplement, N-2 
Supplement and 1% penicillin/streptomycin 5,000 U/l (all from Invitrogen 
AG, Basel, Switzerland). Betacellulin (Sigma Chemical, Buchs, Switzerland) 
was added in a concentration of 2 nmol/L. 
 
RNA isolation and Reverse transcription (RT) 
Total RNA was extracted using TRIzol reagent (Lucerna Chemie AG, Luzern, 
Switzerland) according to the manufacturer’s protocol. RNA samples were 
treated with DNase (Ambion, Cambridgeshire, UK) in order to remove 
possible genomic DNA. RNA was quantified spectrophotometrically at 260 
nm (Biophotometer, Eppendorf-Vaudaux, Schönenbuch, Switzerland). The 
quality was assessed by gel electrophoresis on an agarose gel containing 
ethidium bromide (EtBr, BioRad Laboratories AG, Reinach, Switzerland). 1 µg 
of total RNA was subjected to reverse transcription (RT) (Omniscript RT kit; 
Quiagen, Basel, Switzerland). Negative controls without reverse transcriptase 
enzyme were run in parallel to exclude possible contamination. Human islet 
RNA was a gift from Wolfgang Moritz, University Hospital Zürich, 
Switzerland.  
 
Standard polymerase chain reaction (PCR) 
PCR was performed on a conventional thermal cycler (TGradient, Biometra, 
Göttingen, Germany) using PCR Taq core kit (Qiagen) and 2µl of cDNA. 
Primers were as mentioned in table 1. PCR product identity was confirmed by 
nucleotide sequencing (Microsynth AG, Balgach, Switzerland).  
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Quantitative Real-Time polymerase chain reaction (PCR) 
Quantitative real-time PCR analysis was performed with the ABI 7000 
Sequence (Perkin Elmer, USA) detection system. Specific primers yielding 
short PCR products suitable for Sybr-Green (Abgene, Epsom, UK) detection 
were designed with Primer Express software (version 2.0; PE Applied 
Biosystems, Foster City, CA).The list of primers used is given in table 1. The 
reaction consisted of 50 µL, containing 25 µL Sybr-Green, 2 µL sense primer 
(10 µmol/L), 2 µL antisense primer (10 µmol/L), 16 µL H2O; and 5 µL cDNA. 
Conditions were set as suggested by the manufacturer.  For quantitative 
analysis of gene expression the standard curve method was used [28]. mRNA 
expression for each gene of interest was normalized to Hypoxanthine 
PhosphoRibosyl Transferase (HPRT) expression level that was analyzed with 
the same cDNA. Results were expressed as the ratio of the respective gene 
mRNA and HPRT mRNA threshold values. Data are given as percentage 
expression as compared to day 0.Expression studies were done in 
quadruplicate (i.e. 4 wells were analyzed independently) for each data point  
and  mean values were calculated for each day. For estimation of mRNA 
expression as compared to human islets several developmental genes including 
insulin, glucagon and glut2 were also analyzed in human islets. The relative 
mRNA expression in differentiated MSC on day 3 was calculated as the ratio of 
the expression level in differentiated MSC divided by gene expression found in 
human islets.  The product identity was confirmed by sequence analysis.  The 
interindividual variability of gene expression ranged from 9.1 x 1011 to 1.3 x 
1014 for HPRT (raw data), from 8.9x10-4 to 3.4x10-2 for ABCG2 (normalized to 
HPRT) and from 8.3x10-7 to 3.4x10-3 for Isl-1 (normalized for HPRT). Similar 
variation was observed for the other genes.   
 
Peptide measurements 
Somatostatin concentration was determined in culture supernatants using a 
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commercially available somatostatin radioimmunoassay (RIA) kit (functional 
assay sensitivity: somatostatin 5 pg/tube, Phoenix Pharmaceuticals Inc., 
Belmont, CA).  
 
Immunocytochemistry  
Cultured MSC were transferred into Lab-Tek chamber slides (Nunc, 
Naperville, IL) and incubated overnight in expansion medium. Islet-like 
clusters were collected after 3 days in differentiation medium. Some of them 
were dissociated by trypsin-ethylenediaminetetraacetic acid (EDTA) in order 
to obtain single cells. Single cells or islet-like clusters were transferred on 
glass slides coated with poly-L-lysine (Sigma, Buchs, Switzerland) and 
incubated overnight in DMEM/F12 medium containing 10% FBS allowing 
them to attach. All cells were then fixed with 4% paraformaldehyde in PBS 
(pH 7.4) for 30 min at room temperature. After several rinses in PBS, cells 
were permeabilized with chilled methanol for 10 min. Unspecific binding was 
prevented by incubation with 10 % heat inactivated FBS in PBS at RT for 30 
min. Fixed cultured MSC were incubated with primary antisera for 3 h at RT 
or overnight at 4°C, rinsed off with PBS and incubated with secondary 
antisera for 1 h at RT. Fixed islet-like clusters or single cells were incubated 
with primary antisera for 60-90 min at 37°C, rinsed off with PBS and 
incubated with secondary goat antisera for 45 min at 37°C. After several 
washes with PBS, cells were coverslipped with non-fluorescing mounting 
medium. The primary antibodies used were as follow: Mouse monoclonal 
antibody 39.4D5 (Developmental Studies Hybridoma Bank, University of 
Iowa, IA) raised against Isl1 (dilution 1:100), rabbit anti nestin (dilution 1:500) 
(Chemicon, Juro Supply, Lucerne, Switzerland), rabbit anti-human C-peptide 
for dispersed cells (dilution 1:500) (Linco, St. Charles, MO), sheep anti-human 
C-peptide for islet like cluster (dilution 1:100) (Abcam, Cambridge, MA) and 
rabbit anti- glucagon (dilution 1:100) (Linco, St. Charles, MO). The rabbit anti-
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human Ipf1 (dilution 1:1,000) was a generous gift from J.F. Habener, Boston, 
MA. The secondary antibodies from Molecular Probes (Invitrogen AG, Basel. 
Switzerland) were goat anti-mouse (dilution 1:1,000), donkey anti-sheep 
(1:100) and, goat anti-rabbit (dilution 1:1,000). Goat anti mouse IgG and 
donkey anti-sheep IgG were labeled with alexa fluor 488 dye. Goat anti rabbit 
IgG was labeled with alexa fluor 546 dye. 4, 6-diamidino-2-phenylindole 
(DAPI, 5 µg/ml) from Sigma (Basel, Switzerland) was used to label the nuclei 
(10 min at 37°C). Cells were then examined either by fluorescence microsope 
(Axiophot, Zeiss, Germany) or by confocal microscope (LSM 510, Zeiss, 
Germany).The insulinoma cell line INS-1E served as positive control for Isl-1 
staining and was kindly provided by Claes Wollheim, Geneva, Switzerland. 
Hela cells were from ATCC (Manassas, VA). 
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Results 
Isolation of MSC of non-diabetic subjects 
Human bone marrow derived MSC from five independent donors were 
isolated on the basis of adhesion to tissue culture dishes and proliferation in 
FGF-2 containing culture medium. The initial population of mononuclear cells 
purified by Ficoll density gradient technique was positive for classical 
markers of haematopoietic cells like CD45 and c-Kit but also ABCG2 that is 
known to be expressed in erythroid precursors and natural killer lymphocytes 
(Fig. 1a). They were negative for Thy-1, nestin and Isl-1. During the process of 
MSC isolation haematopoietic cells don’t adhere to plastic surface and are 
discarded with medium change leading to loss of CD45 positive cells. 
Consequently, proliferating MSC were negative for CD45, according to their 
non-haematopoietic origin and showed a strong expression of SCF and Thy-1, 
markers typically expressed in MSC (Fig. 1a). C-kit mRNA expression was 
clearly reduced as compared to initial population of mononuclear cells (Fig.1 
a). In addition, MSC expressed nestin, ABCG2 and Isl-1 mRNA (Fig. 1a). 
Staining for nestin showed that the majority of the cells were positive for this 
stem cell marker (Fig. 1b). Immunocytochemistry revealed Isl-1 protein in the 
nuclei of approximately 10% of cultured MSC (Fig. 1d,f).  
 
Induction of differentiation  
Induction of differentiation was performed in serum-free medium (17.5 mM 
glucose) supplemented with exendin-4, pentagastrin, activin-A, betacellulin, 
nicotinamide and hepatocyte growth factor. Over the three day period we 
could observe a sharp decrease in the expression level of the stem cell marker 
ABCG2 (Fig. 2a). This was mirrored by up-regulation of Isl-1, Ipf-1, Ngn-3 
and Pax-6 (Fig. 2a).  In addition, we observed an up-regulation of the glucose 
transporter glut-2, insulin, glucagon and somatostatin (Figure 2b).  
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After having finished the first series of quantitative real time PCR studies we 
also analyzed the expression of additional transcription factors of the β-cell 
lineage i.e. Pax-4, Nkx2.2 and Nkx6.1 using standard PCR technique. As 
compared to undifferentiated cells these developmental markers were also 
up-regulated at day 3 (Fig. 3).  
 
Analysis of islet proteins in differentiated MSC 
Formation of islet like clusters was observed already 24 hours after initiation 
of the differentiation process (Figure 4a). For immunocytochemistry analysis 
of Ipf-1 cells in the cluster were dissociated, and stained with the Ipf-1 
antiserum. Cells that stained positive for Ipf-1 after 3 days displayed a nuclear 
staining pattern (Figure 4b). Ipf-1 was not detected in undifferentiated cells 
(data not shown). C-peptide and glucagon positive cells were found in 
differentiated islet-like cluster (Fig. 4c-f). Although insulin or glucagon release 
was not found in differentiated islet like clusters we were able to measure 
somatostatin release into the culture medium. Somatostatin was detectable 
already 24 hours after initiation of differentiation and reached plateau levels 
at days 2 and 3 (Fig. 4g). 
When compared to adult human islets the expression levels for the 
transcription factors Ipf-1, Isl-1,  Ngn-3 and Pax-6 found in our islet like 
cluster reached values of 0.07%, 21%, 290% and 20% respectively, of the 
expression levels found in human islets. Conversely, the corresponding 
values for mRNA expression for glut2, somatostatin, glucagon and insulin 
reached 6.1%, 0.2%, 0.3% and less than 0.01% of the values found in human 
islets. 
Differentiation of bone marrow derived MSC from type 1 diabetic patients 
We next sought to determine if MSC from type 1 diabetic patients would also 
be able to adopt a pancreatic endocrine phenotype. Bone marrow derived 
MSC from three patients with long-standing type 1 diabetes expressed similar 
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stem cell markers during the expansion period together with Isl-1 as did MSC 
from non-diabetic subjects (Fig. 5). In proof of principle experiments 
induction of differentiation resulted in an up-regulation of the transcripts for 
Ipf-1, Ngn-3 as well as glut-2, insulin, somatostatin and glucagon as 
illustrated in table 2. Although all three patients with diabetes expressed Isl-1 
and ABCG2 in proliferating MSC and up-regulated insulin, glucagon and 
somatostatin mRNA during the differentiation period we observed a 
substantial variation in the expression level of these genes between patients 
(table 2). C-peptide was also detected with immunocytochemistry on single 
dispersed cells (Fig. 6)  
 
Discussion 
The data presented herein show that human bone marrow-derived MSC are 
able to adopt a pancreatic endocrine phenotype ex vivo in non-diabetic 
subjects as well as patients with longstanding type 1 diabetes. This was 
achieved without genetic modification of the cells and in response to defined 
culture conditions. Initially these cells were cultured in high glucose (25mM) 
and FGF (5ng/ml) and expressed not only the stem cell markers nestin and 
ABCG2 but also the transcription factor Isl-1. ABCG2 is a known marker for 
the side population phenotype stem cells in bone marrow [20] and was 
recently found in pancreatic islet derived precursor cells and neural stem cells 
[19,29]. Together with Isl-1 it may thus point to a subpopulation of MSC with 
a neuro-endocrine developmental potential. During the differentiation 
experiments a strong down-regulation of ABCG2 gene expression was 
observed indicating that the cells indeed changed their developmental state 
from a stem cell to a more differentiated cell type. ABCG2 however is known 
to be expressed not only in stem cells but also in erythroid precursors and 
natural killer lymphocytes [20]. Both cell populations are initially co-purified 
by Ficoll density gradient leading to the positive ABCG2 signal (Fig.1) in the 
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primary mononuclear cell population that was isolated from the bone marrow 
and contain mostly haematopoietic cells. During the expansion period 
however only CD45 negative cells continued to proliferate indicating a non-
haematopoietic origin of these cells.  In addition classical markers for MSC 
were up-regulated like Thy-1 and SCF. Similar cells are routinely 
differentiated into adipocytes or osteoblasts in our institution [30,31] 
demonstrating their mesenchymal phenotype.  
The transcription factor Isl-1 is crucial for the development of pancreatic 
endocrine cells. Disruption of Isl-1 expression is associated with absence of 
dorsal mesenchyme and a marked reduction of Ipf-1 gene expression in 
dorsal epithelium in mice [24]. Embryonic explants of the pancreatic anlage 
from Isl-1 (-/-) mice did not generate insulin, glucagon or somatostatin 
positive cells in vitro as did explants from Isl-1 (+/-) animals [24]. Isl-1 
expression is found at embryonic day 9 in the mouse and is together with Ipf-
1 one of the earliest pancreatic markers detected during development [24]. We 
hypothesize that induction of Isl-1 expression in human MSC may represent 
the primary critical event that allows adoption of a pancreatic endocrine 
phenotype. Signals in the culture medium that triggered Isl-1 expression in a 
subpopulation of MSC could be the high glucose concentration, FBS, FGF-2 or 
all factors together. The exact mechanisms however, remain to be elucidated.  
Beside its crucial role for development of pancreatic endocrine cells Isl-1 is 
also involved in the development of the central nervous system and the heart 
[32-35]. Therefore, some of these Isl-1 positive MSC could also represent 
potential progenitors for motor neurons [32] or cardiomyocytes [35].  
Using serum-free medium supplemented with factors known for their 
beneficial effects on differentiation of pancreatic or hepatic precursors into 
insulin producing cells [36-39] we have induced the activation of various 
crucial pancreatic transcription factors including Ipf-1, Ngn-3, Pax-4, Pax-6, 
Nkx-2.2 and Nkx-6.1 as well as the islet genes insulin, glucagon, somatostatin 
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and glut-2. The differentiation process in vitro described herein may represent 
-at least in part- replication of ontogeny in response to the defined culture 
conditions. Noteworthy, these results were obtained in normal subjects as 
well as in patients with diabetes mellitus type 1 and, without genetic 
manipulation of MSC. As a limitation, these cells were not yet able to secret 
insulin or glucagon (data not shown) indicating a certain level of 
developmental immaturity although they did secrete somatostatin. 
Somatostatin however is also produced by neural cells and formation of such 
neural cells cannot be excluded in our cell culture system. Viewing the very 
low expression of insulin as compared to human islets we are still far away 
from clinically meaningful insulin production in bone marrow derived MSC. 
But, for the first time we show that cultured human MSC may have such 
potential without genetic modification.    
 
The real time PCR studies over 3 days revealed that many pancreatic genes 
were activated already 24h after induction of differentiation. These profound 
changes in the transcriptional program occurred surprisingly fast. But, 
observations of early activation of insulin gene expression were also made in 
mice in vivo in response to hyperglycaemia [40]. Here the authors found 
insulin positive cells in the bone marrow and adipose tissue of 
hyperglycaemic mice already after 3 days. These cells could represent MSC as 
described in the present study and our previous report showing induction of 
pancreatic developmental genes in human adipose tissue derived MSC [28] 
and they could share properties of MSC isolated from pancreatic islets [41].   
 
Several studies addressed the possibility that bone marrow derived stem cells 
could contribute to β-cell turnover in vivo. Some of them presented positive 
results and suggested the presence of a circulating pool of stem cells that 
could participate in the process of β-cell neogenesis [8]. These results however 
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were not confirmed by others [42] and a recent report questioned the entire 
concept of β-cell stem/progenitor cells with studies using genetic lineage 
tracing experiments [43]. With this approach it has been shown that pre-
existing β-cells rather than adult stem/progenitor cells retained a proliferative 
capacity and may thus represent the major source of new β-cells in adult life, 
at least in mice [43]. While in vivo studies are not conclusive regarding the role 
of adult stem cells for generation of new β-cells this does not exclude the 
differentiation of adult stem cells into insulin producing cells in vitro. It has 
been shown that mouse mesenchymal stem cells from bone marrow cultured 
in high glucose over 4 months induced several β-cell specific genes including 
insulin and glut-2 [9]. These cells were also able to reverse hyperglycaemia in 
an animal model of diabetes although other crucial transcription factors like 
Pax4 and Isl-1 were not expressed [9]. In accordance with this report by Tang 
et al. our human MSC are also CD45 negative and express nestin during the 
expansion period.  
In summary Isl-1 positive MSC can be isolated from human bone marrow and 
are able to adopt a pancreatic endocrine phenotype in non-diabetic as well as 
type 1 diabetic subjects. These cells could be used as a human model to study 
development of pancreatic endocrine cells ex vivo and may help to develop 
stem cell based therapies for diabetes mellitus type 1.  
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Figure legends 
 
Figure 1.  
Expression of stem cell markers in mononuclear cells and MSC. (a) Presence of 
CD45, c-kit, ABCG2, SCF, Thy1, nestin and Isl-1 mRNA was analyzed by RT-PCR in 
freshly isolated mononuclear cells (Ficoll separation) and after the 6th passage in 
expansion medium. (b) Immunocytochemistry for nestin, (c) HeLa cells served as 
negative control.for nestin antibody. (c-g) Immunocytochemistry for the transcription 
factor Isl-1 (panels d and f, magnification x 200). Arrows indicate positive staining in 
nuclei of MSC. Nuclei were counterstained with DAPI. Positive control was carried 
out with INS1E cells (right panels e and g). 
 
Figure 2.  
Induction of pancreatic developmental genes in MSC in response to defined culture 
conditions in non-diabetic subjects. Gene expression was monitored every 24h for 3 
days. Data are normalized to HPRT and expressed as percentage expression as 
compared to day 0. Results are means ± SEM of quadruplicates of six independent 
experiments from five independent donors. (a) mRNA expression of the side 
population marker ABCG2 and the pancreatic transcription factors, Isl-1, Ipf-1, Ngn-
3 and Pax-6 was analyzed by real-time PCR. (b) Induction of glut-2, insulin, 
somatostatin and glucagon (logarithmic scale).  
 
Figure 3.  
Expression of Pax4, Nkx2.2 and Nkx6.1 mRNA. Analysis was performed by 
conventional PCR before (day 0) and 3 days after induction of differentiation. This 
experiment was repeated 3 times with MSC from 3 different donors, who were already 
analyzed with realtime PCR.  
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Figure 4.  
Analysis of islet like clusters generated from MSC. (a) Phase contrast image of islet 
like clusters after differentiation of MSC (magnification x 200). For 
immunocytochemistry islet-like clusters were collected after 3 days in differentiation 
medium. Some of them were dissociated by trypsin-EDTA to obtain single cells that 
were stained for Ipf-1 (b). Undifferentiated MSC were negative for Ipf-1. (c-d) Staining 
of differentiated clusters for c-peptide and glucagon (magnification x 400). The panels 
(e-f) show the non-specific affinity of the secondary antibodies. Images were obtained 
with a laser scanning confocal microscope. Nuclear staining in blue with DAPI. (g) 
Somatostatin release during the differentiation period was measured with RIA in 
supernatants collected each day (n=8). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.  
Expression of stem cell markers in MSC from Type 1 diabetic patients. (a) Presence 
of CD45, c-kit, ABCG2, SCF, Thy1, nestin and Isl-1 mRNA was analyzed by RT-PCR 
after the 6th passage in expansion medium.  
 
Figure 6.  
Immunocytochemistry for c-peptide in differentiated MSC of patients with type 1 
diabetes (DBM1, DBM2 and DBM4). The c-peptide positive cells were scattered 
single cells. Staining for c-peptide was absent in all MSC before induction of 
differentiation.  
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Table 1.  
Primer sequences for RT-PCR. All primers were run at 60ºC. 
 
gene sense primer antisense primer 
amplic
on 
accession 
number  
cycles 
HPRT 5´-TCAGGCAGTATAATCCAAAGATGGT-3´ 5´-AGTCTGGCTTATATCCAACACTTCG-3´ 85bp M26434 40 
Insulin 5´-GCAGCCTTTGTGAACCAACA-3´ 5´-TTCCCCGCACACTAGGTAGAGA-3´ 69bp NM_000207 40 
Ipf-1 5´-TGATACTGGATTGGCGTTGTTT-3´ 5´-TCCCAAGGTGGAGTGCTGTAG-3´ 70bp NM_000209 40 
ABCG2 5´-GGTTACGTGGTACAAGATGATGTTG-3´ 5´-AGCCGAAGAGCTGCTGAGAA-3´ 80bp AY289766 40 
Pax-4 5´- TCTCCTCCATCAACCGAGTC -3´ 5´- GTTGGAAAACCAGACCCTCA -3´ 299bp AF043978 40 
Pax-6 5´-TGCGACATTTCCCGAATTCT-3´ 5´-GATGGAGCCAGTCTCGTAATACCT-3´ 81bp NM_001604 40 
Nkx2.2 5´- TCTACGACAGCAGCGACAAC -3´ 5´- TTGTCATTGTCCGGTGACTC -3´ 154bp O95096 40 
Nkx6.1 5´- TCTTCTGGCCCGGAGTGA-3´ 5´- CCAACAAAATGGATCCTTGATGA-3´ 84bp NM_006168 40 
Isl-1 5´-CAACTGGTCAATTTTTCAGAAGGA-3´ 5´-TTGAGAGGACATTGATGCTACTTCAC-3´ 75bp NM_002202 40 
Nestin 5´- CGTTGGAACAGAGGTTGGAG -3´ 5´- TAAGAAAGGCTGGCACAGGT -3´ 396bp BC032580 40 
Glut-2 5´-AGCACTTGGCACTTTTCATCAG-3´ 5´-GCCCAAGATAAATTCAAGACCAAT-3´ 82bp J03810 40 
Ngn-3 5`-CTATTCTTTTGCGCCGGTAGA-3` 5`-CTCACGGGTCACTTGGACAGT-3` 73bp NM_020999 40 
Somatost 5´-GATGCCCTGGAACCTGAAGA-3´ 5´-CCGGGTTTGAGTTAGCAGATCT-3´ 82bp BC032625 40 
Glucagon 5´-CCCAAGATTTTGTGCAGTGGTT-3´ 5´-CAGCATGTCTCTCAAATTCATCGT-3´ 80bp NM_002054 40 
Thy-1 5´-GTCCTTTCTCCCCCAATCTC-3´ 5´-GGGAGACCTGCAAGACTGTT-3´ 239bp NM_033209 40 
SCF 5´-GGTGGCAAATCTTCCAAAAG-3´ 5´-TCTTTCACGCACTCCACAAG-3´ 222bp BC074725 40 
c-kit 5´-GGCATCACGGTGACTTCAAT-3´ 5´-GGTTTGGGGAATGCTTCATA-3´ 244bp L04143 40 
CD45 5´-CAGGCAGCAATGCTATCTCA-3´ 5´-CTGTGATGGTGGTGTTGGAG-3´ 153bp Y00638 40 
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Table 2.  
Quantitative real time PCR analysis of pancreatic developmental genes in MSC of 
three type 1 diabetic patients during the 3 days differentiation period. Values are 
given as percentage expression as compared to day 0. Each experiment was run in 
quadruplicate. In patient 3 Ipf-1 and Glut-2 expression were not detectable (ND) on 
day 0. Therefore day 1 was taken as reference for comparison with days 2 and 3.  
  
 
 patient 1 patient 2 patient 3 
ABCG2 day0 100 100 100 
ABCG2 day1 41 21 116 
ABCG2 day2 14 53 4 
ABCG2 day3 49 1 24 
IPF-1 day0 100 100 ND 
IPF-1 day1 1328 168 100 
IPF-1 day2 1990 0 242 
IPF-1 day3 2746 9431 16 
ISL-1 day0 100 100 100 
ISL-1 day1 53 71 109 
ISL-1 day2 38 210 117 
ISL-1 day3 67 135 228 
NGN-3 day0 100 100 100 
NGN-3 day1 221 112 1022 
NGN-3 day2 417 4455 1521 
NGN-3 day3 3463 7708 1501 
Pax-6 day0 100 100 100 
Pax-6 day1 110 81 4889 
Pax-6 day2 112 81 894 
Pax-6 day3 61 5 1678 
Glut-2 day0 100 100 ND 
Glut-2 day1 233 201 100 
Glut-2 day2 251 1933 185 
Glut-2 day3 2068 2599 313 
SRIF day0 100 100 100 
SRIF day1 58 220 1402 
SRIF day2 121 248 25636 
SRIF day3 444 83 9064 
glucagon day0 100 100 100 
glucagon day1 265 251 1366 
glucagon day2 378 8155 16980 
glucagon day3 1049 974 4658 
Insulin day0 100 100 100 
Insulin day1 99 850 56 
Insulin day2 263 198 5743 
Insulin day3 865 166805 7377 
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Abstract
Mesenchymal stem cells (MSC) from mouse bone marrow were shown to adopt a pancreatic endocrine phenotype in vitro and to
reverse diabetes in an animal model. MSC from human bone marrow and adipose tissue represent very similar cell populations with
comparable phenotypes. Adipose tissue is abundant and easily accessible and could thus also harbor cells with the potential to differen-
tiate in insulin producing cells. We isolated human adipose tissue-derived MSC from four healthy donors. During the proliferation
period, the cells expressed the stem cell markers nestin, ABCG2, SCF, Thy-1 as well as the pancreatic endocrine transcription factor
Isl-1. The cells were induced to differentiate into a pancreatic endocrine phenotype by defined culture conditions within 3 days. Using
quantitative PCR a down-regulation of ABCG2 and up-regulation of pancreatic developmental transcription factors Isl-1, Ipf-1, and
Ngn3 were observed together with induction of the islet hormones insulin, glucagon, and somatostatin.
 2006 Elsevier Inc. All rights reserved.
Keywords: Mesenchymal stem cells; Isl-1; Human; Adipose tissue; Nestin; ABCG2; Differentiation; Insulin; Glucagon
Mesenchymal stem cells have been initially described as
clonal, plastic adherent cells from bone marrow [1] capable
of differentiating into adipocytes, chondrocytes, and osteo-
blasts [2,3]. They have been later identified in various other
tissues including muscle, brain, and adipose tissue [4–6]. In
addition to their ability to differentiate into adipocytes,
osteoblast, and chondrocytes, these stem cells were also
found to adopt a neural and hepatic phenotype in vitro
and in vivo [7–12]. Proliferating MSC express the stem cell
marker nestin [9,11,13], a gene initially characterized as a
marker of neural stem or progenitor cells [14] and later also
suggested to be a marker for multipotent pancreatic stem
cells [15]. MSC from mouse bone marrow were recently
shown to harbor the potential to differentiate into insulin
secreting cells in vitro and to reverse hyperglycemia in an
animal model of diabetes [16]. Similarly, mesenchymal
CD45-negative precursor cells from mouse spleen were able
to regenerate insulin producing cells in a mouse model of
autoimmune diabetes [17]. The mechanisms underlying this
apparent developmental plasticity of MSC are unknown.
MSC from human bone marrow and adipose tissue repre-
sent a very similar cell population with comparable pheno-
types [6,18–20]. Thus, MSC with the potential to adopt a
pancreatic endocrine phenotype could also exist in human
adipose tissue. In the light of the actual worldwide diabetes
epidemic, the generation of insulin producing cells from
adipose tissue-derived stem cells represents an attractive
treatment option for patients who have lost their residual
insulin production. In the present study, we show that
MSC from human adipose tissue express the stem cell
markers nestin and ABCG2, and display the potential to
activate pancreatic developmental genes in response to
0006-291X/$ - see front matter  2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.bbrc.2006.01.072
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defined culture conditions. This includes the transcription
factors Ipf-1, Isl-1, Ngn-3, and Pax-6 as well as the islet
proteins insulin, glucagon, and somatostatin.
Materials and methods
Isolation and expansion of human adipose tissue-derived MSC. Human
adipose tissue was obtained from patients undergoing plastic surgery in
accordance with the Local Ethics Committee (University Hospital Basel,
Switzerland). Adipose tissue-derived MSC were isolated and expanded as
previously described [21]. Culture medium contained DMEM supple-
mented with 10% fetal bovine serum (FBS) and 5 ng/mL fibroblast growth
factor (bFGF), 1% sodium pyruvate MEM 100 mM, and 1% penicillin/
streptomycin 5000 U/mL (all from Invitrogen, Basel, Switzerland). MSC
were cultured in 175 cm2 Flasks (Becton–Dickinson AG, Basel, Switzer-
land). Medium was changed twice a week. At a confluence of 95%, cells
were collected using trypsin (Invitrogen AG, Basel, Switzerland) and
washed twice with DMEM/F12 medium.
For induction of differentiation, the cells were seeded at a cell density
of 2–3 · 105/well of a 6-well plate and cultured for 3 days in ultra-low
attachment plates (Vitaris AG, Baar, Switzerland). MSC from four donors
were analyzed at passages 4–7. The gene expression profile of each dif-
ferentiation study was analyzed every 24 h for 3 days in every subject. For
each differentiation day cells from four separate wells were harvested and
analyzed independently and a mean value was calculated. Differentiation
medium consisted of serum-free DMEM/F12 medium with 17.5 mM
glucose in the presence of nicotinamide 10 mM, activin-A 2 nM, exendin-4
10 nM, hepatocyte growth factor 100 pM, and pentagastrin 10 nM (all
from Sigma, Basel, Switzerland) as well as B-27 serum-free supplement,
N-2 Supplement, and 1% penicillin/streptomycin 5000 U/L (all from
Invitrogen AG, Basel, Switzerland).
RNA isolation and reverse transcription. Total RNA was extracted
using TRIzol reagent (Lucerna Chemie AG, Luzern, Switzerland)
according to the manufacturer’s protocol. RNA samples were treated
with DNase (Ambion, Cambridgeshire, UK) in order to remove
possible contaminating genomic DNA. RNA was quantified spectro-
photometrically at 260 nm (Biophotometer, Eppendorf-Vaudaux,
Scho¨nenbuch, Switzerland). The quality was assessed by gel electro-
phoresis on agarose gel containing ethidium bromide (EtBr, Bio-Rad
Laboratories AG, Reinach, Switzerland). One microgram of total RNA
was subjected to reverse transcription (RT) (Omniscript RT kit; Qia-
gen, Basel, Switzerland).
Polymerase chain reaction. Polymerase chain reaction (PCR) was
performed on a conventional thermal cycler (TGradient, Biometra,
Go¨ttingen, Germany) using PCR Taq core kit (Qiagen). Human gene-
specific, intron spanning primers were used as mentioned in Table 1
with exception of primer for Ipf-1 and insulin that were used for real-
time PCR. Amplification products were visualized on agarose gels
containing 0.5 lg/mL EtBr. 100 bp Molecular Ruler (Bio-Rad, Reinach,
Switzerland) was run as size reference. PCR product identity was
confirmed by nucleotide sequencing (Microsynth AG, Balgach,
Switzerland).
Quantitative real-time polymerase chain reaction. cDNA, obtained as
described above, was subjected to quantitative real-time PCR analysis
using the ABI 7000 Sequence (Perkin-Elmer, USA) detection system.
Specific primers yielding short PCR products suitable for Sybr-Green
(Abgene, Epsom, UK) detection were designed using Primer Express
software (version 2.0; PE Applied Biosystems, Foster City, CA). For
sequences of primers, see Table 1. The reaction consisted of 50 lL, con-
taining 25 lL Sybr-Green, 2 lL sense primer (10 lmol/L), 2 lL antisense
primer (10 lmol/L), 16 lL H2O, and 5 lL cDNA. Conditions were set as
suggested by the manufacturer. Each cDNA sample tested for quantitative
gene mRNA expression was also subjected to hypoxanthine-phosphori-
bosyltransferase (HPRT) mRNA analysis. Results were expressed as the
ratio of the respective gene mRNA and HPRT mRNA threshold values.
Gene induction in differentiated cells is expressed as percentage of values
found in undifferentiated MSC. The product identity was confirmed by T
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sequence analysis and electrophoresis on a 3% agarose gel containing
EtBr.
Peptide measurements. Somatostatin concentration was determined in
culture supernatants using a commercially available somatostatin radio-
immunoassay (RIA) kit (functional assay sensitivity: somatostatin 5 pg/
tube, Phoenix Pharmaceuticals, Belmont, CA).
Immunocytochemistry. Cultured MSC were transferred on glass slides
and incubated overnight in expansion medium. Islet-like clusters were
collected after 3 days in differentiation medium and dissociated by trypsin-
ethylenediaminetetraacetic acid (EDTA) in order to obtain single cells.
Single cells were transferred on glass slides coated with poly-L-lysine
(Sigma, Buchs, Switzerland) and incubated overnight in DMEM/F12
medium containing 10% FBS allowing them to attach. Cells were then
fixed with 4% paraformaldehyde in PBS (pH 7.4) for 30 min at room
temperature. After several rinses in PBS, cells were permeabilized with
chilled methanol for 10 min. Unspecific binding was prevented by incu-
bation with 10% heat-inactivated FBS in PBS at RT for 30 min. Cells were
incubated with primary antisera for 60–90 min at 37 C, rinsed off with
PBS, and incubated with secondary goat antisera for 45 min at 37 C.
After several washes with PBS, cells were coverslipped with non-fluo-
rescing mounting medium. The primary antibody rabbit anti-human
c-peptide (dilution 1:500) was from Linco, St. Charles, MO. Mouse anti-
Isl-1 (dilution 1:100) (number 39.4D5) was obtained from Developmental
Studies Hybridoma Bank, University of Iowa, IA. The rabbit anti-human
Ipf-1 (dilution 1:1000) was a generous gift from J.F. Habener, Boston,
MA. The secondary antibodies from Molecular Probes (Invitrogen AG,
Basel, Switzerland) were goat anti-mouse (dilution 1:1000) and goat anti-
rabbit (dilution 1:1000). Goat anti-mouse IgG was labeled with Alexa
fluor 488 dye. Goat anti-rabbit IgG was labeled with Alexa fluor 546 dye.
4,6-Diamidino-2-phenylindole (DAPI, 5 lg/mL) from Sigma was used to
label the nuclei (10 min at 37 C). Cells were examined by fluorescence
microscope (Axiophot, Zeiss, Germany).
Results
Human adipose tissue-derived MSC from four donors
were isolated and proliferated in bFGF containing culture
medium. The initial cell population was positive for stem cell
factor (SCF) and its receptor (c-kit). This cell populationwas
negative for ABCG2, nestin, Thy-1, and Isl-1 as assessed by
RT-PCR (Fig. 1A). Proliferating MSC, however, expressed
ABCG2, nestin, Thy-1, and Isl-1 mRNA (Fig. 1A). Using
immunocytochemistry we found Isl-1 protein in the nuclei
of approximately 10% of cultured MSC (Fig. 1B). The mes-
enchymal characteristic of adipose tissue-derived MSC was
described by previous studies [6,18–20] and confirmed with
internal control experiments showing adoption of adipocytic
and osteocytic phenotypes of these cells in response to stan-
dard protocols (data not shown).
Induction of pancreatic endocrine differentiation with
our defined culture conditions was associated with step-
wise decrease in the expression level of the stem cell
marker ABCG2 as analyzed by quantitative real-time
PCR. This was mirrored by up-regulation of Isl-1, Ipf-
1, and Ngn-3 expression during the observed 3-day peri-
od (Fig. 2). Interestingly, expression of Pax-6 was also
found in proliferating MSC and was not further induced
by the 3-day differentiation procedure. Genes known to
be positively regulated by Ipf-1 like insulin and somato-
statin were also induced during the differentiation period.
In addition, an activation of glucagon gene expression
was observed (Fig. 3).
Nuclear staining for Ipf-1 was found in approximately
10% of the cells after 3 days (Figs. 4A and B). Ipf-1 was
not detected by immunocytochemistry in undifferentiated
cells. C-peptide positive cells were found in differentiated
MSC (Figs. 4C and D). In addition, we found a release
of somatostatin into the medium that reached plateau lev-
els at day 3 (Fig. 4E).
Discussion
The present study demonstrates that human adipose
tissue-derived MSC are able to adopt a pancreatic endo-
crine phenotype ex vivo. This was achieved without
genetic modification and in response to defined culture
conditions. Initially, these cells were cultured in high glu-
cose (25 mM) and bFGF (5 ng/mL) and expressed after
expansion not only the stem cell markers nestin, ABCG2,
SCF, and Thy-1 but also the pancreatic transcription fac-
tor Isl-1 (Fig. 1). ABCG2 is a known marker for the side
population phenotype stem cells in bone marrow [22]
and was recently found in pancreatic islet-derived precur-
sor cells and neural stem cells [23,24]. Together with Isl-1
it may thus point to a subpopulation of MSC with
Fig. 1. Expression of stem cell markers in adipose tissue-derived MSC.
(A) Presence of ABCG2, SCF, c-kit, nestin, Thy1, and Isl-1 mRNA was
analyzed by RT-PCR in primary cell isolates and MSC (passage 6) in
expansion medium. (B) Immunocytochemistry for the transcription factor
Isl-1 (magnification 400·). Arrows indicate positive staining. Nuclei were
counterstained with DAPI (in blue). (For interpretation of the references
to color in this figure legend, the reader is referred to the web version of
this paper.)
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neuro-endocrine developmental potential. The transcrip-
tion factor Isl-1 is crucial for the development of pancre-
atic endocrine cells. Disruption of Isl-1 expression is
associated with absence of dorsal mesenchyme and a
marked reduction of Ipf-1 gene expression in dorsal epi-
thelium in mice [25]. Embryonic explants of the pancre-
atic anlage from Isl-1 (/) mice did not generate
insulin, glucagon or somatostatin positive cells in vitro
as did explants from Isl-1 (+/) animals [25]. Isl-1
expression is together with Ipf-1 one of the earliest pan-
creatic transcription factors detected during development
[25]. Induction of Isl-1 expression in our human MSC
Fig. 3. Induction of the islet genes insulin, glucagon, and somatostatin in adipose tissue-derived MSC in response to defined culture conditions.
Fig. 2. Induction of pancreatic developmental genes in adipose tissue-derived MSC in response to defined culture conditions. Gene expression was
monitored every 24 h for 3 days. Data are normalized to HPRT and expressed as percentage expression as compared to day 0. Results are means ± SEM
of quadruplicate of four independent experiments from four independent donors. mRNA expression of pancreatic transcription factors Isl-1, Ipf-1, Ngn-3,
and the side population marker ABCG2 and Pax-6 was analyzed by real-time PCR.
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may represent a critical event that allows adoption of a
pancreatic endocrine phenotype. Other early markers of
pancreas development like Ipf-1 and Ngn-3 were not
detected by PCR in undifferentiated cells.
Using serum-free medium supplemented with factors
known for their beneficial effects on differentiation of pre-
cursor cells into insulin producing cells (i.e., exendin-4,
pentagastrin, activin-A, betacellulin, nicotinamide, and
hepatocyte growth factor) [26–29] we have induced an acti-
vation of pancreatic transcription factors including Ipf-1,
Isl-1, Ngn-3, as well as the islet proteins insulin, glucagon,
and somatostatin. The real-time PCR studies revealed an
activation of some of these pancreatic genes already 24 h
after induction of differentiation (Figs. 2 and 3). Similar
early induction of insulin gene expression was reported
recently in mice in vivo in response to hyperglycemia
[30]. Here, insulin positive cells were identified in adipose
tissue, spleen, and also bone marrow of hyperglycemic mice
after 3 days.
Several studies addressed the possibility that bone mar-
row-derived stem cells could contribute to b-cell turnover
in vivo. Some of them presented positive results, suggest-
ing a circulating pool of stem cells that could participate
in the process of b-cell neogenesis [31]. These results, how-
ever, were not confirmed by others [32] and a recent
report questioned the entire concept of b-cell stem/pro-
genitor cells with studies using genetic lineage tracing
experiments [33]. With this approach it has been shown
that pre-existing b-cells rather than adult stem/progenitor
cells retained a proliferative capacity and may thus repre-
sent the major source of new b-cells in adult life, at least
in mice [33]. While in vivo studies are not conclusive, this
does not exclude the differentiation of adult stem cells
into insulin producing cells in vitro. It has been shown
that mouse mesenchymal stem cells from bone marrow
cultured in high glucose over 4 months induced several
b-cell-specific genes including insulin and Ipf-1 [16]. These
cells were also able to reverse hyperglycemia in an animal
model of diabetes [16].
In summary, Isl-1 positive MSC can be isolated from
human adipose tissue and are able to adopt a pancreatic
endocrine phenotype. These cells could be used as a human
model to develop stem cell-based therapies for diabetes
mellitus.
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